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Preface
Reproducibility is a core tenet for conducting and validating scientific 
investigations and thus producing high-quality research. The reproducibility 
of a result or finding is a fundamental goal in science. Often, investigators, 
publishers of journals, and others give low priority to results or findings 
that are merely confirmatory of previous findings. Increasingly, however, 
this narrow focus on “new” research results is seen as a challenge to 
scientific progress and to the acceptance of research (or science and the 
scientific method) by the public at large. This growing acknowledgment 
of the importance of reproducibility has been accompanied by rising 
confusion about this and related concepts, such as repeatability, replicability, 
transparency, and quality. Globally, experts are pointing to the muddled 
state of affairs in terms of understanding the literal and technical meanings 
of these constructs—and using them correctly. Conflating the terms 
undermines communication across scientific disciplines and endeavors 
and makes the practical processes of ensuring rigorous multidisciplinary 
research more difficult.
We consider the issues about reproducibility to be core elements of 
high-quality research. Most research organizations have formal expectations 
and policies or programs setting standards for high-quality research. 
For example, RTI’s commitment to robust research is articulated in its 
own quality manual. Its goal is to ensure excellence for all RTI’s products 
and services, from project conception through completion and delivery 
of research data and final reports, as well as for publications in peer-
reviewed journals, the RTI Press, and other venues. The challenges, and the 
motivation for this publication, lie more in understanding concepts around 
reproducibility—their similarities and differences, their nuances, and their 
applications in everyday scientific activities.
Late in 2015, RTI International’s Fellow Program lent its support for 
a small group of Fellows to explore issues relating to reproducibility, 
replication, transparency, and rigor in the research enterprise. The group 
regarded “research” as encompassing a full range of scientific endeavor, 
technical services and assistance, and similar work done across RTI. A 
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smaller set of this group developed a background report, which eventually 
became this monograph. Appendices to this monograph highlight some 
practices and resources that are pertinent to the broader requirements of 
reproducible or transparent research.
To help sort through this confusing environment and offer a common 
understanding and lexicon across disciplines, we have developed this primer. 
We hope that it will advance the nation’s portfolio of scientific research—for 
those engaged in the laboratory, natural, clinical, and social sciences—and 
ensure that users can address the issues of reproducibility and rigor with 
confidence and conviction.
—Edo Pellizzari, Kathleen Lohr, Alan Blatecky, and Darryl Creel
August 2017
Introduction
“Non-reproducible single occurrences are  
of no significance to science.” 
—Karl Popper, 1959
CHAPTER 1
Background and Context
Science is allegedly in the midst of a reproducibility crisis,1 but questions of 
reproducibility and related principles date back nearly 80 years.2 Further, 
since at least the beginning of the 2010s, numerous controversies in a variety 
of disciplines have arisen stemming from failure to reproduce studies or their 
findings, and reproducible research has become a critical issue in scientific 
discourse.3 Scientists across numerous disciplines have expressed serious 
concerns and engaged in both philosophical and practical discussions about 
reproducible research. Disciplines represented in these discussions include 
biology,4 biomedical5 and preclinical research,6,7 business and organizational 
studies,8-12 computational sciences,13,14 drug discovery,15 economics,16,17 
education,18-22 epidemiology and statistics,23-25 genetics,26 immunology,27 
policy research,28 political science,29-36 psychology,29,37-43 and sociology.44 
As a case in point: research indicates that more than half of psychology 
studies fail reproducibility tests.41,45 A team of highly regarded researchers, 
many of them authors of the studies under review, attempted to reproduce 
100 experimental and correlational studies published in three psychology 
journals41,45 using the reported designs and original materials when available. 
The results: (1) 62 percent of the replication attempts failed, (2) the reported 
replication effects sizes were approximately half the magnitude of the original 
effects, and (3) although 97 percent of the original studies reported statistically 
significant results at the 95 percent confidence threshold, only 36 percent of 
replicated studies found significant results at that same threshold.41,45 
Subsequently, a team of psychologists led by Gilbert and colleagues 
claimed that their analysis, which tried to reproduce what the Open Science 
Collaboration had done, completely invalidated the pessimistic conclusions 
that had been drawn from the landmark study.46,47 The disagreements between 
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the conclusions of these two major studies stem from differences in statistical 
methods used and interpretations of statistical results obtained. 
The growing chorus of concern, from scientists and laypeople alike, is 
that reproducibility of biomedical research is failing.48,49 The US National 
Institutes of Health (NIH) shares this concern. Collins and Tabak, for example, 
cite several problems.5 These are chiefly deficits in experimental design that 
ignore fundamental properties of statistical theory, which may occur in part 
because of improper or inadequate training, incomplete documentation of 
experimental design, and a need to maintain a “competitive edge” by making 
provocative statements rather than presenting technical details about the 
research in question.5 To these concerns one might add the lack of incentives, 
time, and resources, which hinders many scientists from trying to reproduce 
earlier work. All these issues have contributed to the lack of reproducibility in 
the biomedical sciences.5 
Similarly, computational science (sometimes rendered as scientific 
computing) faces a credibility crisis.14,50 Computational science is a rapidly 
growing, multidisciplinary field that uses sophisticated computer capabilities 
(hardware, software, and advanced analytic techniques or modeling) to 
solve complicated problems in the biological, physical, and social sciences. 
Computing results are often presented rather loosely in journal articles, at 
conferences, and in books.14 Researchers cannot always verify most of the 
computational results presented at conferences and in papers today.14 Too 
often computations are taken at face value—by both experts and the public at 
large. 
The state of reproducible research was further exposed in a 2016 Nature 
survey of 1,576 researchers. The survey results revealed that “more than 
70 [percent] of researchers have tried and failed to reproduce another 
scientist’s experiments, and more than half have failed to reproduce their own 
experiments.”1 Among those surveyed, 52 percent believed that the crisis is 
significant, 32 percent believed it was only slight, and 3 percent did not believe 
a crisis even exists. Furthermore, “73 [percent] of the respondents believe 
that at least half of the papers in their field can be trusted, with physicists and 
chemists generally showing the most confidence.”1 Microbiologist Casadevall 
adroitly described the status of reproducible research: “At the current time 
there is no consensus on what reproducibility is or should be.”1 
More people have more access to data than ever before, and more of them 
are attempting to publish their analyses than ever before. The Office of Science 
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and Technology Policy has been promoting, or even requiring, that federal 
science agencies plan to make research data available to the public, industry, 
and the scientific community.51 US agencies such as the NIH and the National 
Science Foundation have begun to require that data from all awards be made 
widely available.52 When this trend toward open access to data is coupled 
with the rapid growth and importance of data-intensive research across all 
the domains of science, many new issues arise and more common questions 
become more complicated to address. Private-sector foundations also voice 
concerns.53
In particular, use, reuse, and management of data—and of course issues 
of reproducibility and replication—become increasingly critical. Provenance, 
governance, and curation of data, personal identifiers, and metadata must 
be adequately addressed; if they are not, reproducibility or replicability 
becomes impossible. This is especially the case if scientific agencies do not 
establish policies to require more detailed information about how their 
investigators generated and analyzed their data and do not provide resources 
for reproducing studies.
Moreover, inadequate analytical skills can produce scientific findings that 
are neither replicable nor reproducible (and have done so).54 High-profile 
cases have been reported in several research fields. Examples include the 
inability to reproduce Reinhart and Rogoff ’s work on the ratio of debt to gross 
domestic product55 and Regnerus’ New Family Structures Study of children 
with same-sex parents.56,57 The retraction of the LaCour and Green work 
on transmission of support for gay equality was actually a case of fabrication 
of data (scientific misconduct),58 but it was identified through an effort 
to reproduce the original study and so we include it here. Other types of 
studies have reported similar reproducibility outcomes.6,57 Issues of scientific 
misconduct, such as deliberate fabrication of data and findings, and rising 
emphasis on issues of both financial and nonfinancial conflicts of interest, are 
beyond the scope of this monograph.
The fact that, in many cases, the original authors were willing to have their 
work scrutinized suggests that scientific misconduct was not a reason for 
failure in reproducibility. What it does indicate is that widespread publication 
of work, when seen by other investigators after publication, may well not stand 
up to scrutiny. 
A major reason for this outcome has been characterized as unconscious 
bias.59 Often, researchers fool themselves, especially in the data analysis phase, 
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and follow their “instincts.” However, when large number of variables are 
involved in such research, instincts can no longer be trusted.60 The significant 
growth of science and continued emphasis on publication both contribute to 
this dilemma. 
Private-sector, academic, and nonprofit groups are leading multiple efforts 
to reproduce selected published findings. So far, the results do not make happy 
reading.61 As indicated at the beginning of this chapter, several high-profile 
endeavors were unable to reproduce the large majority of peer-reviewed 
studies that they examined. These efforts have taken place in many fields, 
including biology, biomedical, chemistry, economics, medicine, psychology, 
and sociology.1,61 Meanwhile, additional discussions and a recent study by 
the US National Academies of Sciences, Engineering, and Medicine entitled 
“Fostering Integrity in Research” highlight the importance of addressing 
scientific integrity and reproducibility for the nation’s research enterprise.62
Practical Considerations
Because of ongoing trends among leading peer-reviewed journals, research 
funders, and others who are addressing these issues, authors increasingly need 
to pay close attention to reproducibility issues in all their research publications. 
Such attention begins, ideally, at the outset of the research, but it carries 
through to final publication of research results. 
For example, some journals waive length restrictions or provide for 
web-based supplemental materials (i.e., appendices) to facilitate reporting 
methodological details.5 Others promulgate publication review criteria that 
specifically consider the ability to replicate or reproduce reported results.63 
Finally, as of late 2016, more than 30 journals, associations, and professional 
societies, particularly in the biomedical realm, have agreed to endorse 
principles and guidelines for reporting preclinical research.64 These principles 
and guidelines cover rigorous statistical analysis, transparency in reporting, 
sharing of data and materials, and inclusion of image-based data and 
descriptions of biological material in decisions about manuscript acceptance 
and publication.64
A second consideration is the potentially substantial cost implications of 
thoroughly planning for and addressing reproducibility issues.65 Such costs 
may be based, at least in part, on the degree of scrutiny that is proposed to 
address reproducibility issues throughout the study and publication of results. 
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Although pursuing a comprehensive plan may entail considerable work and 
costs at the outset, the benefits to doing so may be substantial as well.14
A third, and possibly knottier problem, is that even though scientists agree 
about a “crisis” for carrying out reproducible research, they are unable to agree 
on what “reproducibility” means.66 The proliferation of related concepts, such 
as repeatability and replicability (and multiple subsets of these constructs), 
as well as notions of transparency and documentation or of scientific 
rigor, robustness, and quality, simply add to the confusion. Misuse and 
misunderstanding ensue, and communication about the problems becomes 
confusing, hampering decisions about addressing the issues.
Adding to the problem is a belief, among both experts and the public at 
large, that scientists cannot or will not adopt a universal (i.e., shared) definition 
of reproducibility (or the related terms). That is, instead of advocating for 
commonly agreed-upon definitions of this term, some leading scientists have 
proposed expanded sets of terms and terms with various distinctions. Whether 
or how this trend might illuminate the issues and reduce the conceptual and 
lexicographical muddle remains to be seen. 
The complex (not to say chaotic) nature of animal, human, social, and 
physical systems imposes limitations on reproducing (or repeating, or 
replicating) scientific experiments and other types of studies. Thus, we 
acknowledge that high-quality research can be, but may not be, reproducible or 
replicable.67 It should, however, always be transparent and fully documented. 
Finally, it should be robust enough to assure scientists and laypeople alike 
about the confidence they can have in reported findings and ensuing policies 
that society may want to adopt.
Purpose of This Monograph
To address these conceptual, definitional, and practical issues, a group 
established by the RTI International Fellow Program began in 2015 to develop 
a primer on the topic. Its remit included examining the semantics of the 
terminology and exploring some key implications for the research enterprise 
broadly conceived. The main audience is scientists and researchers who are 
not, at present, steeped in the debate.
The motivation was, in part, a belief that appreciating the nuances of 
reproducibility may help researchers to communicate about problems of “one-
off ” study results or of apparently differing findings from studies that purport 
to repeat earlier investigations. We also aimed to provide some background 
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and a platform for later documents or educational tools that can examine 
quality and transparency in the projects being conducted by the research 
community. We believe that such information in a reference document can 
help to forestall “non-reproducible” research and promote rigorous, high-
quality research. We hope to help scientists and society as a whole have 
confidence in the integrity of the work and the soundness of published 
findings. Finally, we sought to present the semantics of reproducibility and 
reproducible research, because those ideas cross numerous disciplines of 
research.
In the next chapter, we define several main concepts and terms relating 
to reproducible research and show how they differ from (or are consistent 
or inconsistent with) authoritative definitions across the bench sciences and 
the social sciences. In the following chapters, we draw out some universal 
themes that can help scientists from different natural and social sciences 
backgrounds to communicate clearly, collaborate productively, and generate 
reliable, valid, and believable information to guide future research and policy. 
We also address practical steps for assuring transparent, valid, and high-quality 
research, particularly with respect to publishing such work. Our concluding 
chapter recaps major points. Appendices A and B cover detailed or technical 
issues about regulated research and subsets of concepts such as transparency.
Definitions of Concepts and Terms
CHAPTER 2
Introduction
Figure 1 depicts the concepts that we address in this monograph. Our basic 
premise is that high-quality research is closely associated with concepts such as 
being accurate, reproducible, replicable, and repeatable—all underpinned by 
the idea that these scientific endeavors are transparent and valid. Definitions of 
these concepts are provided in Tables 1 and 2 and the accompanying text.
Figure 1. Key concepts of high-quality research 
Reproducible
Accurate High-Qualiy 
Research Repeatable
Replicable
Transparent Valid
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The most authoritative source that we cite for the definitions of terms is 
the National Institute of Standards and Technology (NIST; https://www.nist.
gov). Across both natural or bench science and the social and policy sciences, 
NIST offers the most well-known and respected foundation for clarifying 
and standardizing the lexicon for scientific communication across fields 
and disciplines. We discuss these key concepts next, relying on NIST when 
possible; when not, we offer dictionary definitions or cite interpretations or 
definitions from other scientific experts. 
Key Concepts and Related Definitions
For the key concepts presented in Figure 1, Table 1 provides authoritative 
definitions, some common alternatives that appear to be consistent with NIST 
definitions, and definitions that are inconsistent with NIST definitions. We rely 
chiefly on definitions from NIST; others derive from organizations such as the 
International Union of Pure and Applied Chemistry and other expert groups. 
We either adopted (i.e., repeat verbatim, identified in Table 1 by quotation 
marks) or paraphrased definitions from longer discussions in the literature 
cited at the end of the table. Our goal for the latter step was to make the 
definitions succinct. 
For this monograph, we are using NIST definitions as the standard lexicon. 
We believe that basing our vocabulary on NIST definitions will be helpful 
for scientists and researchers working not just in their own fields but also 
in multidisciplinary teams for whom conflicting definitions can muddle 
communications.
Of particular importance is the crucial distinction between reproducibility 
and replicability. The differences lie mainly in whether every element of a 
given study must be done in exactly the same way in any effort either to 
do it again or to confirm original results. That requirement is basically the 
“restrictive” aspect of replicability. By contrast, reproducibility does not turn 
so critically on such elements as having identical subjects, methods, and other 
components; that is, at least one component differs from the original research 
study. Making a clear distinction is important when gauging the credibility 
of a study’s outcome or conclusion because its integrity generally increases 
from replication to reproduction, when investigators vary one, several, or all 
components. 
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Table 1. Definitions and extensions of key concepts for science and research
Key Concepts
Definitions Adapted from the 
National Institute of Standards 
and Technology (NIST)
Definitions in Common Parlance and 
Their Consistency with NIST Definition
Quality “It is an encompassing term 
comprising utility, objectivity, and 
integrity of research.” a 
Utility “means disseminated 
information is useful to its 
intended users.” a 
Objectivity “means the information 
is accurate, reliable, and unbiased, 
and that information products are 
presented in an accurate, clear, 
complete, and unbiased manner.” a 
Integrity “means information is 
safeguarded from improper access, 
modification, or destruction.” a 
• An attribute of research that is measured 
against a formal or informal standard and 
that reflects the degree of excellence (or 
lack of it) of that research.b 
Comment: Consistent with NIST definition. 
Accuracy A qualitative term referring to 
the “closeness of the agreement 
between the result of a 
measurement and the value of the 
measurand.” c
• “The degree to which the result of a 
measurement, calculation, or specification 
conforms to the correct value or a 
standard.” b 
• “The quality or state of being correct or 
precise.” b
Note: Accuracy implies precision or 
exactness owing to the care with which the 
information was assembled. 
Comment: Consistent with NIST definition.
Reproducibility The “closeness of the 
agreement between the 
results of measurements of 
the same measurand carried 
out under changed conditions 
of measurement” (from an 
experiment or nonexperimental 
study using different conditions, 
such as a different principle of 
measurement, different method 
of measurement, different 
individuals, and different 
locations).c
• The ability to be reproduced or copied.b
• As reproducibility relates to the quality 
of an endeavor, it is the “variation in 
the average measurements of different 
appraisers who measure the same items 
using the same measuring equipment.” d 
Comment: Consistent with NIST definition.
“Where independent investigators subject 
the original data to their own analyses 
and interpretations. Reproducibility calls 
for data sets and software to be made 
available for (1) verifying published findings, 
(2) conducting alternative analyses of the 
same data, (3) eliminating uninformed 
criticisms that do not stand up to existing 
data, and (4) expediting the interchange of 
ideas among investigators.” e
Comment: Consistent with NIST definition.
continuedBold added for emphasis
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Table 1. Definitions and extensions of key concepts for science and research
Key Concepts
Definitions Adapted from the 
National Institute of Standards 
and Technology (NIST)
Definitions in Common Parlance and 
Their Consistency with NIST Definition
Reproducibility 
(continued)
• “The ability of a researcher to duplicate 
the results of a prior study using the same 
materials and procedures as were used by 
the original investigator.”f
Consistent with NIST definition if an 
independent investigator repeats the work. 
Otherwise, if the same investigator repeats 
the work, then this is the definition for 
replicability. 
• “The ability to recompute data analytic 
results given an observed dataset and 
knowledge of the data analysis pipeline.”g
Comment: Consistent with NIST definition 
if an independent investigator repeats the 
work. Otherwise, if the same investigator 
repeats the work, then this is the definition 
for replicability.
Repeatability The “closeness of agreement 
between the results of successive 
measurements of the same 
measurand carried out under the 
same conditions of measurement” 
(measurement procedure, 
observer, measuring instrument, 
and location).c
• The closeness of agreement between 
independent results obtained when the 
same study is replicated on identical 
test material or subjects, using the same 
measurement procedure, same observer, 
same measuring instrument, the same 
location and under the same conditions.h 
Comment: Consistent with NIST definition.
Replicability NIST does not formally address 
replicability. 
NIST does, however, use the term 
in specific applications without 
defining it or distinguishing it 
from repeatability (see above). 
Replicability can be (or not be) 
consistent with repeatability. 
Another distinction is that 
replicability is the act of repeating 
exactly, whereas repeatability 
is a measure of the closeness of 
the act. 
We focus on replicability rather 
than repeatability because the 
scientific literature tends to use 
the former term, but does so in 
conflicting ways. 
• “The ability to obtain an identical result 
when an experiment is performed under 
precisely identical conditions.” i
Comment: Consistent with implicit NIST 
definition.
• “The ability of a researcher to duplicate 
the results of a prior study if the same 
procedures are followed but new data are 
collected.” f
Comment: Consistent with implicit NIST 
definition, assuming it is the original 
researcher performing the work. 
• “The chance that an independent 
experiment targeting the same scientific 
question will produce a consistent result.” g 
Comment: Inconsistent with implicit 
NIST definition. This is the definition of 
reproducibility.
(continued)
Bold added for emphasis
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Table 1. Definitions and extensions of key concepts for science and research
Key Concepts
Definitions Adapted from the 
National Institute of Standards 
and Technology (NIST)
Definitions in Common Parlance and 
Their Consistency with NIST Definition
Replicability 
(continued)
• “Replicated by multiple independent 
investigators using independent data, 
analytical methods, laboratories, and 
instruments.” e
Comment: Inconsistent with implicit 
NIST definition. This is the definition of 
reproducibility.
Transparency “A matter of showing how you 
obtained the results being 
disseminated.” a
• The clarity and completeness of any 
scientific report, the extent to which 
intended audiences can readily 
understand that report, and the extent to 
which it provides full disclosure and is free 
of obfuscation or evasion.
Comment: Consistent with NIST definition. 
Validity NIST does not formally address 
validity. The concept is not 
subsumed in any other concept 
defined by NIST.
• “The quality of being logically or factually 
sound.”b
• The extent to which a concept, 
measurement, or conclusion is well-
founded and corresponds accurately to 
the real world. j 
• The ability to achieve accuracy and 
reproducibility in an experiment or 
nonexperimental study.
• Whether a scientific claim is true and 
whether data analysis can be trusted.
• The degree to which the tool (e.g., a test 
in education; a battery of patient-reported 
outcomes; an instrument in chemistry) 
measures what it claims to measure.
• In the area of scientific research design 
and experimentation, whether a study is 
able to answer scientifically the questions 
it is intended to answer.
a  NIST, 201668 
b  English Oxford Living Dictionaries, 201769
c  Taylor and Kuyatt, 1994;70 Joint Committee for 
Guides in Metrology (JCGM), 201271 
d  MiC Quality, n.d.72 
e  Peng et al. 200623 
f  Bollen et al., 201573
g  Leek and Peng, 201574 
h  McNaught and Wilkinson, 199775
i  Casadevall and Fang, 201027
j  Scientific Advisory Council of the Medical 
Outcomes Trust, 200276
Bold added for emphasis
(continued)
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Table 2 documents more thoroughly terms related to aspects of high-quality 
research (as in Figure 1) and, in particular, reproducibility. We note when these 
entries are consistent with NIST definitions for a given concept and when they 
are not; the latter situation arises because, in many cases, the definition for a 
specific concept is more relevant for a different concept.
Table 2. Taxonomies and new, expanded, or overlapping terms, phrases, or concepts 
for science and research
Term or 
Phrase
Available Definitions, Descriptions, 
or Explanations
Consistency with NIST 
Definition and Recommended 
Change if Needed
Reproducibility
Methodological 
reproducibilitya
“Ability to implement, as exactly 
as possible, the experimental and 
computational procedures, with the same 
data and tools, to obtain the same results.” a
Comment: Inconsistent with NIST 
definition. This is the definition of 
repeatability.
Recommended change: Ability to 
implement different experimental 
procedures, with the same or 
independent data and tools, to 
obtain the same results.
Results 
reproducibilitya
“The production of corroborating results in 
a new study [by] having followed the same 
experimental methods.” a
Comment: Inconsistent with NIST 
definition. This is the definition of 
repeatability.
Recommended change: The 
production of corroborating 
results in a new study by having 
followed different experimental 
methods.
Inferential 
reproducibilitya
“The making of knowledge claims of 
similar strength from a study replication or 
reanalysis.” a
Comment: Inconsistent with NIST 
definition. This is the definition of 
repeatability.
Recommended change: The 
making of knowledge claims of 
similar strength between the 
original and reproduced studies
Empirical 
reproducibilityb
When detailed information is provided “for 
non-computational empirical scientific 
experiments” and observations.b
Comment: Consistent with NIST 
definition, except that this 
definition mainly addresses 
enabling an independent 
investigator to reproduce an 
experiment or study.
No change.
Bold added for emphasis
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Table 2. Taxonomies and new, expanded, or overlapping terms, phrases, or concepts 
for science and research
Term or 
Phrase
Available Definitions, Descriptions, 
or Explanations
Consistency with NIST 
Definition and Recommended 
Change if Needed
Reproducibility (continued)
Statistical 
reproducibilityb
When detailed information is provided 
about the choice of statistical tests, model 
parameters, threshold values, etc.b
Comment: Consistent with NIST 
definition, but mainly addresses 
enabling an independent 
investigator to reproduce an 
experiment or study.
No change.
Computational 
reproducibilityb
When detailed information is provided 
about code, software, hardware, and 
implementation details.b 
Comment: Consistent with NIST 
definition, but mainly addresses 
enabling an independent 
investigator to reproduce an 
experiment or study.
No change.
Analytical 
reproducibility
When detailed information is provided that 
enables independent analysts to reproduce 
the logical, modeling, and computational 
processes by which the original 
investigators had drawn their conclusions 
from a given database.
Comment: Consistent with NIST 
definition.
No change.
Reproducible 
research when 
it satisfies 
transparency 
criteriac
Providing detailed description of methods, 
documenting the computer code and 
software environment, making the 
analytical data set available to other 
investigators, and following standard 
methods of distribution for other 
investigators to access the software, data, 
and documentation.c 
Comment: Consistent with 
NIST definition, but is mainly a 
subcategory that is contingent on 
transparency.
No change.
Repeatability conditions
Same 
measurement 
proceduresd
Can include patients or populations; 
interventions; control groups or active 
comparators; and intermediate or final 
outcomes. They can also include a variety of 
study design and analytic statistics.d
Comment: Consistent with 
NIST definition, but is mainly 
an elaboration describing the 
condition.
No change.
Same 
measuring 
instrumentsd
Can cover a wide range of instruments, from 
laboratory equipment to patient-reported 
questionnaires, used under the same 
conditions.d
Comment: Consistent with 
NIST definition, but is mainly 
an elaboration describing the 
condition.
No change.
Same locationsd Can include laboratories, field sites, health 
facilities, educational settings, community 
settings, and homes.d
Comment: Consistent with 
NIST definition, but is mainly 
an elaboration describing the 
condition.
No change.
continued
(continued)
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Table 2. Taxonomies and new, expanded, or overlapping terms, phrases, or concepts 
for science and research
Term or 
Phrase
Available Definitions, Descriptions, 
or Explanations
Consistency with NIST 
Definition and Recommended 
Change if Needed
Repeatability conditions (continued)
Repetition 
over a short 
period of time 
or the same 
measurement 
periodsd
Applies particularly to bench science 
projects, or the same measurement periods 
for other types of experiments or studies, 
especially when the results or outcomes 
have time as a variable.d
Comment: Consistent with 
NIST definition, but is mainly 
an elaboration describing the 
condition.
No change.
Replicability
No additional 
terms
Not applicable Not applicable
Categories of quality or related activities
Quality 
assurancee
In general: Use of planned and systematic 
activities to ensure that research and 
services meet client-specific requirements. 
Audits are conducted to ensure that 
research staff are following the procedures 
as prescribed in standard operating 
procedures and protocols.e
In health care: “[A] full cycle of activities 
and systems for maintaining the quality of 
patient care.”f
Comment: Consistent with NIST 
definition. Mainly an elaboration 
describing the condition as it 
applies to research or to health 
care.
No change. In health care, 
this term is related to quality 
improvement (see below).
Quality controle Use of operational techniques and activities 
to monitor work processes and detect 
and eliminate causes of unsatisfactory 
performance as the research is being 
performed.e 
Comment: Consistent with NIST 
definition. Mainly an elaboration 
describing the condition.
No change.
Quality, quality 
measurement,  
or quality 
assessment in 
health caref
In general: Quality is defined in Table 1.
In health care: In 1990, the Institute of 
Medicine defined quality (for health care) 
as “the degree to which health services for 
individuals and populations increase the 
likelihood of desired health outcomes and 
are consistent with current professional 
knowledge.” f
In general: Quality measurement of 
assessment is the use of tools to measure or 
quantify processes and outcomes of a given 
service.
In health care: “Quality assessment is 
the measurement of the technical and 
interpersonal aspects of health care and the 
outcomes of that care . . . [and] is expressly a 
measurement activity.”f
Comment: Consistent with NIST 
definition. Mainly an elaboration 
describing the condition as it 
relates to health care.
No change.
(continued)
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Table 2. Taxonomies and new, expanded, or overlapping terms, phrases, or concepts 
for science and research
Term or 
Phrase
Available Definitions, Descriptions, 
or Explanations
Consistency with NIST 
Definition and Recommended 
Change if Needed
Categories of quality or related activities (continued)
Quality 
improvement; 
continuous 
quality 
improvementg
In general: Use of various formal approaches 
to analyze performance and implement 
systematic efforts to improve it.
In health care: "Quality improvement entails 
continuous efforts to achieve stable and 
predictable process results, that is, to reduce 
process variation and improve the outcomes 
of these processes both for patients and the 
health care organization and system."g
Comment: Consistent with NIST 
definition. Mainly an elaboration 
describing the condition as it 
relates to health care.
No change.
Categories of transparent research
Reviewable 
researchh
“The descriptions of the research methods 
can be independently assessed and the 
results judged credible.” h
Comment: Consistent with NIST 
definition.
No change. 
Replicable 
researchh
“Tools are made available that would 
allow one to duplicate the results of the 
research.” h
Comment: Inconsistent with NIST 
definition. This is related more to 
a basic definition of reproducible 
research.
Recommended change: 
Reproducible research—Making 
available tools that would allow 
independent researchers to 
reproduce the results of their 
research.
Confirmable 
researchh
“The main conclusions of the research can 
be attained independently without the use 
of software provided by the author.” h
Comment: Not applicable 
comparison to NIST definition.
No change.
Auditable 
researchh
“Sufficient records (including data and 
software) have been archived so that the 
research can be defended later if necessary 
or differences between independent 
confirmations resolved.” h
Comment: Not applicable 
comparison to NIST definition.
No change.
continued
(continued)
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Table 2. Taxonomies and new, expanded, or overlapping terms, phrases, or concepts 
for science and research
Term or 
Phrase
Available Definitions, Descriptions, 
or Explanations
Consistency with NIST 
Definition and Recommended 
Change if Needed
Categories of transparent research (continued)
Open or 
reproducible 
researchh
“Auditable research made openly available. 
This comprise[s] well-documented and 
fully open code and data that are publicly 
available that would allow [others] to 
(a) fully audit the [study procedures and 
computations], (b) replicate and also 
independently reproduce the results of the 
research; and (c) extend the results or apply 
the method to new problems.” h
Comment: Consistent with NIST 
definition.
No change.
Verificationh “Checking that the computer code [that the 
original investigators describe] correctly 
solves the mathematical problem it claims 
to solve.” h
Comment: Not applicable 
comparison to NIST definition.
No change.
Validationh “Checking that the results of a computer 
simulation agree with experiments or 
observations of the phenomenon being 
studied.” h
Comment: Not applicable 
comparison to NIST definition.
No change.
Validationh “Checking that the results of a computer 
simulation agree with experiments or 
observations of the phenomenon being 
studied.” h
Comment: Not applicable 
comparison to NIST definition.
No change.
Categories of validity
Content or face 
validity
Numerous definitions of types of validity are 
used for measurement.i,j
“Evidence that the domain of an instrument 
is appropriate relative to its intended use.”
Comment: Not applicable 
comparison to NIST definition 
(i.e., NIST does not have 
definitions for these categories of 
validity).
No change.
Construct 
validity (e.g., 
convergent and 
discriminant 
validity)
“Evidence that supports a proposed 
interpretation of scores based on theoretical 
implications associated with the constructs 
being measured.”
Comment: Not applicable 
comparison to NIST definition 
(i.e., NIST does not have 
definitions for these categories of 
validity).
No change.
Criterion (e.g., 
concurrent 
or predictive) 
validity
“Evidence that shows the extent to which 
scores of the instrument are related to a 
criterion measure.”
Comment: Not applicable 
comparison to NIST definition 
(i.e., NIST does not have 
definitions for these categories of 
validity).
No change.
(continued)
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Table 2. Taxonomies and new, expanded, or overlapping terms, phrases, or concepts 
for science and research
Term or 
Phrase
Available Definitions, Descriptions, 
or Explanations
Consistency with NIST 
Definition and Recommended 
Change if Needed
Categories of validity (continued)
Internal validity: 
risk of bias in 
or quality of a 
study
Generally, the following types of validity are 
used to characterize studies: 
Internal validity: “the extent to which the 
design and conduct of a study are likely 
to have prevented bias” k or “the extent to 
which the results of a study are correct for 
the circumstances being studied” l
Risk of bias: the risk of “a systematic error 
or deviation from the truth, in results or 
inferences.” m 
Quality: “the extent to which all aspects 
of a study’s design and conduct can be 
shown to protect against systematic bias, 
nonsystematic bias, and inferential error.” n 
Comment: Not applicable 
comparison to NIST definition 
(i.e., NIST does not have 
definitions for these categories of 
validity).
No change.
External validity: 
generalizability 
or applicability 
of the data from 
a study to other 
populations or 
settings
External validity: “inferences about the 
extent to which a causal relationship 
holds over variations in persons, settings, 
treatments, and outcomes.” o
Applicability: “the extent to which the 
effects observed in published studies are 
likely to reflect the expected results when 
a specific intervention is applied to the 
population of interest under ‘real-world’ 
conditions.” p
Comment: Not applicable 
comparison to NIST definition 
(i.e., NIST does not have 
definitions for these categories of 
validity).
No change.
NIST = National Institute of Standards and 
Technology. For NIST definitions, see Table 1.
a  Goodman et al., 201677 
b  Stodden, 201478 
c  Peng et al., 200623
d  Taylor and Kuyatt, 1994;70 JCGM, 2012;71 
McNaught and Wilkinson, 199775
e  RTI International, 201379
f  Lohr, 199080
g  Knox and Brach, 201381
h  Stodden et al., 2012.82 For more details, see 
Appendix B.
i  Scientific Advisory Committee of the Medical 
Outcomes Trust, 200276
j  Cella et al., 201583
k  Cochrane Collaboration, 200584 
l  Jüni et al., 200185 
m  Viswanathan et al., 201286 
n  Lohr, 200487 
o  Shadish et al., 200288 
p  Atkins et al., 201089 
(continued)
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Explication of Key Concepts
Referring to Figure 1 and the definitions presented in Tables 1 and 2, we use 
this section to provide a broader description of these same concepts. Entries 
in Tables 1 and 2 do not exhaust the possible variations (sometimes minor) in 
definitions that have emerged over the years; the literature for some concepts 
(such as quality or validity) is immense. 
Whereas common jargon is often vague, with intersecting descriptions 
of terms, technical definitions have traditionally been developed to bring 
rigor and specificity that permits distinguishing between terms or concepts. 
Nevertheless, as presented in Tables 1 and 2, contradictions occur between 
technical terms because development of their definitions has not been 
extensively coordinated across disciplines. 
Here, therefore, for each term, we begin with its common parlance. 
Following that, we provide an expanded discussion of technical definitions as 
applied in the physical, natural and social sciences. 
Quality
Quality is an attribute of something—for our purposes, research broadly 
conceived—that is measured against some kind of formal or informal standard 
and that reflects the degree of excellence (or lack of it) of that something 
(i.e., research). Generally speaking, quality is taken to mean high quality. The 
concept, as applied to health care, similar enterprises (such as education), 
and manufacturing has a long history. Seminal work on topics such as 
continuous quality improvement or Six Sigma performance dates from the 
mid-1990s.90-101
Quality can subsume concepts such as the processes or outcomes of an 
activity. These specifically include formal programs intended to ensure the 
quality of something, such as research. Such programs may well entail formal 
quality assurance (QA) or quality control (QC) activities (which are discussed 
more in Appendix A).
Quality as it is applied to research activities or public programs serving 
society as a whole may be defined by national governments (the federal 
government in the United States) or other bodies (both subnational and cross-
national). Such definitions are often cited in laws, regulations, or guidelines. 
Professional societies, for example those for health care practitioners, often 
define quality as well. Research and educational institutions may also issue 
“quality” guidelines, expectations, or manuals for their personnel.79 
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For research and service activities that are formally regulated, US agencies 
and professional or trade associations can and do issue various definitions 
and standards for quality. Appendix A gives examples of such agencies 
or organizations and lists key elements of federally regulated research. 
(Limitations on the scope of our efforts precluded documenting such statutes 
or regulations outside the United States.) 
In some cases, clients supporting nonregulated research projects may also 
require various kinds of QA systems or activities. Nevertheless, most often 
investigators who are not conducting research projects for regulatory agencies 
or purposes are often left to their own discretion on how to implement high-
quality research. Not surprisingly, this fact leads to considerable variability in 
how investigators implement (even similar) studies. 
Finally, in the context of reproducible research, quality refers to the 
internal processes, procedures, and ways of thinking or problem-solving that 
researchers use in conducting defensible and useful research. The specific 
expectation is that investigators (and others) can assume that they have 
produced results that meet two basic criteria: (1) the findings are “correct” or 
“accurate” (within limits of statistical power, defensible decisions about design, 
statistics, and interpretations, and measurable limits) and (2) the findings will 
withstand rigorous scrutiny. 
Accuracy 
Broadly speaking, accuracy is the condition of being correct or truthful. These 
terms—accuracy and correctness—are somewhat interchangeable; here, we use 
accuracy. In common parlance, accuracy implies precision or exactness owing 
to the care with which the information was assembled. In scientific usage, 
accuracy refers to the degree to which the result of a measurement, calculation, 
or specification conforms to a correct value or a well-accepted standard. 
For reproducible research, accuracy is an attribute of the investigation (or 
technical services activity, etc.) that reflects the correctness or truthfulness of 
both the results reported and the attendant interpretations of those results. 
The extent to which this is true places an upper bound on the quality of the 
research. 
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Reproducibility
In the broadest terms, reproducibility has numerous (related) connotations. 
Fundamentally, in common parlance it means making a copy, duplicate, or 
close imitation of something or to cause something to be recreated. In other 
words, reproducibility is the ability to obtain the same result, observation, or 
output from an experiment, a device, a system, a process, or an entire study.102 
We return to more specific considerations about reproducible research in this 
section.
The concept of reproducibility has various technical definitions as well. 
For instance, in measurement terms it can refer to the extent to which some 
observation is (or can be) obtained more than once over some (short or 
long) period of time. (The length of those time periods will differ, perhaps 
drastically, depending on the effect of time as a variable.) As reproducibility 
relates to the quality of an endeavor (and especially in considering the 
quality of health care), it is the “variation in the average measurements of 
different appraisers who measure the same items using the same measuring 
equipment.”72 Reproducibility, in the research context, is the ability of a 
scientific investigation to be repeated or recreated. In principle, the goal is to 
produce equivalent (similar, identical) results and interpretations.
A simple example may clarify the difference between reproducibility and 
repeatability (below). Say the length of a board is measured using a yardstick 
and determined to be 24 inches in length. The board is measured again but 
instead with a tape measure and again found to be 24 inches. The measured 
length of the board has been determined to be the same but using a different 
tool and thus the measurand (quantity) has been reproduced.
Reproducibility is the closeness of agreement between independent results 
obtained when carried out under changed measurement conditions.70,71 
Changed conditions in an experiment or nonexperimental study can include 
different settings, different principles of measurement, different methods of 
measurement, by different individuals, and different locations. The primary 
aim may be simply to verify the original results. Other goals may be to do the 
work again so as to expand the number of subjects (i.e., increase sample sizes 
and thus power); this may be important when the entire body of research 
results is to be the target of, for example, cumulative meta-analysis.
In some fields, original research may show little or no effects (i.e., few if any 
differences between groups, interventions, or other program components). 
Investigators and funders may not want to “reproduce” the work in this sense 
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at all. However, for transparency and documentation, all audiences should be 
able to understand how the original work was accomplished and what, from 
that, seems to merit being retested in the same or similar circumstances. 
Scientists seem to conflate the ideas of reproducible and correct, but they 
are not the same thing. A study can be reproducible and still be wrong. (For 
that matter, a study may be correct yet still not be fully reproducible because of 
design or other factors.) Nevertheless, scientists generally argue that research 
that can be independently reproduced is more reliable than research that 
cannot.
Repeatability
Repeatability is the closeness of agreement between independent results 
obtained when the same method is replicated on identical test material or 
subjects and under the same conditions.70,71 As with the example above, a 
real-world illustration may help clarify differences in these concepts. In the 
above example, repeatability would apply to multiple measurements using 
a yardstick or multiple measurements using a tape measure. Such repeated 
measures yield information about the extent to which results agree when they 
are produced by measurements made using the same tool.70,71 The variation 
between measurements (whether replicated or reproduced) can be expressed, 
for example, by a standard deviation.70,71,75
Replicability
Complicating understanding reproducibility is the notion of replicability. 
The act of making a copy or fully reproducing any one or a combination 
of components is referred to as replicating it. This term is not precisely 
interchangeable with reproducibility, but they are related. Among natural 
and physical scientists, for example, reproducibility refers to achieving the 
same phenomenon or result when experimental conditions or tools used are 
varied to some degree. By contrast, replicability is a more rigorous concept, in 
that it refers to the ability to obtain an identical result when an experiment is 
performed under precisely identical conditions and using the same tools.
Referring to the simple example above: Both methods determine that the 
board is 24 inches long, but reproducing the results of measurement using a 
different tool lends more credence to the claim (or finding) that the board is 
24 inches than does simply replicating it using the same tool. Reproducing 
the finding implies some greater sense of accuracy to the measurement, even 
though the measurement may not be accurate in either case.
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Transparency
In ordinary parlance, transparent or transparency has numerous informal and 
technical definitions. For our purposes, the concept has three main elements: 
the clarity and completeness of any report or information about a given topic; 
the extent to which the report or publication can be readily understood (at 
least by intended audiences); and the extent to which it provides full disclosure 
and is free of obfuscation or evasion.
Transparency is achieved through accurately and adequately 
communicating what was done. In the research context, this is typically done 
through a journal publication or technical report (perhaps including online 
supplemental materials). Thus, transparency can be seen as an enabler for 
achieving reproducible research. 
More specifically, in the context of reproducible research, transparency 
means that all reports of the investigations are complete, accurate, 
understandable, and fully documented. The particulars for documentation 
may differ by scientific field. For instance, ensuring transparency may entail 
thorough descriptions of cell lines, animals, or antibodies and other reagents 
used in biomedical experiments. As another example, transparency requires 
documenting the steps taken in randomizing (or masking/blinding) subjects, 
researchers, and outcomes assessors in animal studies, experimental (e.g., 
clinical) trials, and the like. Federally regulated research, examined more 
fully in Appendix A, places great emphasis on transparency. Transparency 
is discussed further in later sections of this monograph, and Appendix B 
provides more details. 
Researchers should be clear about their work, for example, by presenting 
(or making available) tables of the data that lie behind their graphs and figures. 
Moreover, investigators may need to make the source data available with easy 
access for other investigators or QA auditors to use or critique.
Validity
As with all the terms examined in this paper, validity has several connotations. 
For our purposes, it can be defined as the extent to which a concept, 
measurement, or conclusion is well-founded and corresponds accurately to the 
real world.76,83 The validity of a measurement tool (e.g., a test in education, 
a battery of patient-reported outcomes; an instrument in chemistry) is 
considered to be the degree to which the tool measures what it claims to 
measure. In the area of scientific research design and experimentation, validity 
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refers to whether a study is able to answer scientifically the questions it is 
intended to answer. In ordinary parlance, the question of validity turns on 
whether a scientific claim is true and whether data analysis can be trusted. 
Concluding Thoughts
The independent genesis of quality-related terms at institutions has led 
to conflicting definitions across disciplines. Adopting definitions from an 
authoritative source such as NIST and incorporating them into training 
curricula at academic institutions and promulgating them through, for 
example, the lexicons that professional societies use are important next 
steps. Insofar as many academic institutions that train the next generation of 
researchers do not deliberately educate graduate students and newly minted 
investigators in the issues of inconsistent use of definitions as discussed earlier, 
reproducibility problems will take longer to overcome. 

Reproducing or Replicating Studies: 
Key Considerations and Challenges
CHAPTER 3
Scientific evidence is strengthened when important findings are reproduced, 
replicated, or repeated. As we introduced in Chapter 2, two classes of studies 
are important to distinguish—namely, reproductions and replications. 
Investigators trying to do “the same” study need to choose between (a) 
trying to do the same study (or arrive at the same results) under changed 
conditions—i.e., reproduction, and (b) trying to use the same components of 
the original study under conditions that truly mimic the original work—i.e., 
replication. As numerous observers have noted, keeping the distinctions 
clear is more difficult when people use cognates or different types of words or 
different parts of speech (nouns, verbs, nominalizations) for the concept they 
are trying to discuss. 
The focus needs to be on the outcomes or results of the measurements 
or interventions of the original study or trial in question. As the complexity 
of the system studied increases, the ability to repeat a given study of that 
system generally decreases. In such cases, reproducibility plays a greater role. 
(Repeatability is a research effort allied more closely with replicability than 
reproducibility, and we do not address it further here.) The rest of this chapter 
examines core elements of work to try to reproduce, if not replicate, scientific 
endeavors.
Reproducibility and Replicability 
Reproducibility 
As noted in the previous chapter, reproducibility is the closeness of the 
agreement between results for a given variable coming from the original work 
and those coming from assessments of that variable under changed conditions 
of measurement.27,70,71,75 The later study might be done following the same 
method on identical test material or types of participants in trials but with 
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changes in other study design elements such as additional doses of medications 
or different types of environments or locations).70,71,75 
Reproducibility is a phenomenon that can be predicted to occur 
when experimental conditions may differ to some degree; that is to say, 
reproducibility intrinsically requires changes in some elements of the original 
investigation. If the research cannot be repeated with precisely the same 
subjects, then it cannot be replicated but it can be reproduced to determine 
whether the later study yields the same results or not. Thus, a valid statement 
that describes a second (or later) study attempting to reproduce the first 
requires that subsequent investigators specify which conditions of the 
experiment or study they have changed.
In some social sciences or health research (particularly clinical trials and 
systematic reviews of such evidence), the construct “PICOTS” can be applied 
to understand the parameters of the study. PICOTS refers to populations 
(patients), interventions, 
comparators (which could 
include placebos or active 
interventions of various sorts), 
outcomes measured, time frames 
(for follow-up measurements 
at the end of the intervention 
or later follow-up), and 
settings.103,104 This framework 
is widely used in evidence-based 
health care practice work (e.g., 
systematic reviews105 and their 
protocols106,107) and can be 
applied broadly to much social 
science and clinical research. 
Such specificity facilitates 
designing or describing 
the conditions for studies 
attempting to either replicate 
or reproduce the original 
investigation. Questions related 
to PICOTS are listed in Table 3.
Table 3. Core components related to the 
reproducibility of scientific investigations:  
A PICOTS framework
What is the chief aim of the study? 
What are the main characteristics of the trial or study 
design?
Who or what are the populations or subjects of 
interest?
On whom or what are such measurements made?
What are its measurement or data collection tasks? 
What measurement instruments are used and by 
whom are they administered? 
What reference standards or population norms for 
instruments or questionnaires apply? 
What are the conditions under which study 
measurements are done?
When are measurement(s) made? 
What is the location or setting of the experiment or 
study?
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Conditions relating to reproducibility differ based on the type of research. 
Generally, however, they may involve any or all of the following components of 
an experiment or observational study: 
What is the fundamental principle (mode) of measurement? For example, to 
measure the structure of a chemical, investigators might start first using a mass 
spectrometer with electron bombardment as the principle of measurement. In 
a subsequent investigation, they (or others) may measure the structure of the 
same chemical based on infrared light using an infrared spectrophotometer. 
Other examples of data collection tasks include questionnaires on health-
related quality of life, alternative versions of a standardized test that 
educational programs use, and outcomes assessed for a community-based 
domestic violence initiative—all of which could be modified in various ways.
Who makes the measurement? The individuals assessing the intervention 
or comparator variables and outcomes may be investigators, independent 
outcomes assessors, subjects or patients, administrators of settings, or various 
other persons (equipment operators, technicians, proxies for children, and so 
on). The qualifications for different individuals conducting the measurement 
may vary, possibly affecting the reproducibility of the outcome.
What measurement instrument(s) do the investigators use? These can 
range across many types of hardware, devices, data collection forms, and 
questionnaires of considerable variety. Moreover, instruments can be 
administered, as suggested above, by all kinds of persons involved in the study, 
including the subjects themselves.
What reference standards or population norms apply? These may include 
measurement standards, such as those obtained from NIST for calibrating a 
laboratory instrument. They can also be thresholds for (normal vs. abnormal) 
diagnostic tests or cut points for results from questionnaires or other 
instruments completed by schoolchildren, patients, or other subjects. 
What are the conditions under which studies deploy measurement 
instruments? For example, investigators may need to take into account factors 
such as effects of temperature on the performance of an instrument, schedules 
followed by an educational institution, or the workflow of a private physician 
practice. 
When are measurement(s) made? Timing issues can include baseline 
measures, a single measurement at the end of an experiment or study, or 
multiple measurements during a clinical or after it has ended. Factors to 
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consider include, for example, season of the year, day of the week, and time of 
day. They can also involve the timing of exposure to an intervention and length 
of exposure to the intervention. 
What is the location or setting of the experiment or study? Settings include, for 
instance, laboratories; health or social services facilities; schools; community 
or fraternal organizations; communities, neighborhoods, or villages; homes 
and other residential facilities; and even prisons and jails.
Finally, reproducibility may be expressed quantitatively in terms of the 
dispersion characteristics of the results—e.g., as a standard deviation.70,71,75 
Variance and confidence intervals clarify the uncertainty around estimates 
of outcomes. In comparing original and later findings to determine whether 
they agree (such that the later work confirms or supports the earlier work), 
these statistical elements can be very important for accurately interpreting the 
“reproduced” study and its findings. 
Replicability
As defined in an earlier chapter, replication means that a study conducted 
by the original investigative team develops new independent data, using the 
same analytical methods, laboratories, and instruments. The main feature 
of replication is that the primary elements of the later research are precisely 
similar to the original experiment, trial, or study.27 The core components of 
the research (e.g., the PICOTS) of interest are those outlined in Table 3. 
Replicability describes the act or ability of obtaining an identical result 
when an experiment is performed under precisely identical conditions by the 
original researcher or possibly other scientists. The notion of repeatability, 
which closely mirrors or can subsume replicability, refers to the closeness 
of agreement between the results of successive measurements of the same 
item being measured that are carried out under the same conditions of 
measurement.75 As with reproducible research, differences in results of 
replicated or repeated studies can be expressed quantitatively with dispersion 
characteristics such as standard deviations.70,71,75
Conceptual, Measurement, and Practical Considerations
Natural and physical sciences have a long and rich history of incorporating 
these concepts into research. They play a central role in the conduct of social 
sciences research as well. In all domains, however, investigators need to 
address numerous conceptual and practical aspects of their work. 
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Social sciences research addresses, but is by no means limited to, health 
(including food and nutrition), education, economics, criminal and civil 
justice, housing and urban development, and environmental sciences 
(including energy). Attempts to reproduce scientific research in these fields 
are increasing. Researchers trained in several disciplines, such as economics, 
psychology, political science, business and organizational studies, policy 
research, and sociology, have been increasingly discussing reproduction 
(or even replication) in their various research fields (Caren Arbeit, RTI 
International, personal communication, 2015). 
If results from an experiment or study are concordant when conducted 
by different investigators, then the experiment or study is considered to be 
successfully reproduced, even if it was never replicated.108 In contrast, if the 
results from different investigators differ, myriad possible explanations must be 
considered. Some of these may relate to differences in methods or protocols. 
Because of all the possible explanations, which lead to finer distinctions, 
scientists across the board are more interested in the reproducibility of results 
than in the precise replication of experiments or studies.27,108 
The desirability of showing that later investigations produce the same or 
similar findings (or even discrepant results) leads to the practical question 
of how many times researchers should try to reproduce a given study before 
its results (and conclusions stemming from those results) are accepted.27 
Ideally, an experiment or study should be repeated multiple times before it is 
considered acceptable;27 in practical terms, this scenario is not likely. (Indeed, 
no hard-and-fast rules exist for the number of times that an experiment or 
study should be done over before being accepted.27) Nonetheless, the principle 
remains: reproducing an experiment or study provides assurance that the effect 
or result cannot be attributed to chance alone and that it is not an artifact of 
the experiment or study that yielded a one-time event.27 
Casadevall and Fang explored these issues in greater depth.27 Even though 
the ability of an investigator to confirm an experimental or study result is 
essential to good science, practical and philosophical limits arise in these 
endeavors. As noted in Chapter 1, many examples across numerous fields show 
unconfirmed results in clinical studies, biological experiments, microarray 
results, and research in many other fields. Another lapse is the failure of 
clinical trials based on promising preclinical studies. Such observations have 
led experts to question the validity of the requirement for replication or 
reproduction in science. 
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Why should this question arise? One answer is that confirming results by 
reproduction (or replication, if feasible) is likely to be inversely proportional 
to the number of variables in an experiment or study.27 Every variable 
contains a certain degree of error. Because error can propagate both linearly 
and nonlinearly, one may conclude that the more variables involved, the 
more errors can be expected. This relationship thus reduces the likelihood of 
replicability of any complex experiment or study. 
Costs associated with highly complex experiments and studies raise another 
practical barrier to successful reproduction or replication. Some scientific 
research, especially in areas of public health, involves longitudinal studies 
that are so large and of such great duration that they could not realistically be 
reproduced. A case in point is the renowned Framingham Heart Study, which 
has been ongoing since 1948. In some cases, researchers may try to reproduce 
or replicate findings from important studies using statistical modeling. This 
strategy may obviate the barriers posed by high costs of major trials or large 
observational studies but has its own methodologic limitations. 
Replication can perhaps be done with tightly controlled laboratory 
experiments. It is often impossible, however, when studying the behavior of 
dynamic, complex systems, for example at the intersection of human health, 
the natural environment, and technological risks.61 
When an experiment or study is relatively easily and inexpensively 
carried out, then it behooves investigators to ascertain the reproducibility or 
replicability of a result or finding as fully as possible. Some experts argue that 
the importance of reproducibility increases in proportion to the importance of 
a result.27 Arguably, experiments or studies that challenge existing beliefs and 
assumptions ought to be subjected to greater scrutiny than those fitting within 
established paradigms. 
Barriers to Effective Reproducible Research 
Understanding the definitions of the key terms in this area is crucial for 
scientific discourse and appropriate conduct of research. Equally challenging, 
and important, is recognizing several critical issues that confront responsible 
researchers. In the rest of this chapter we highlight several issues in general 
terms: the multiplicity of terms and the complexity of taxonomies, the great 
diversity in research endeavors across the natural and social sciences, differing 
expectations for regulated and nonregulated research, and the resulting 
patchwork of authoritative guidance about how researchers should proceed.
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Multiplicity of Terms and Concepts
Even when used with respect to the scientific method, the term reproducibility 
apparently has different connotations, depending on its area of application, as 
we noted in Tables 1 and 2. Users may apply it subjectively or quantitatively; 
often, multiple usages are found in research. For example, researchers (and end 
users of that research) may use reproducibility in conjunction with one or all 
of the following:
• the uncertainty of measurements
• the functionality of an instrument or technique (e.g., an instrument 
for making many different kinds of measurements; a tool, form, or 
questionnaire for collecting information)
• the observations associated with a given procedure or intervention (i.e., 
data
• the results obtained from a given algorithm, analysis, statistical test, or 
modeling activity.
As emphasized in Chapter 2, we are advocating adoption of the formal 
definition70,71 from the National Institute of Standards and Technology 
(NIST), which can be found in Table 1. We believe this will reduce the 
confusion and permit researchers across many different disciplines to 
communicate and collaborate with a shared understanding of reproducibility 
(and related constructs that are different in important ways). 
Moreover, as discussed below, research is extremely diverse in the natural, 
physical, and social sciences. Here, we limit the discussion to investigations 
involving human beings; however, in theory the issues extend to studies 
of nonhuman genera and species. Thus, the types of studies that might be 
subject to requirements of reproducibility range widely across all the following 
categories:
• laboratory experiments (e.g., biological, chemical, or physical studies 
with experimental designs)
• clinical trials (e.g., randomized controlled trials of health care 
interventions)
• social science trials (e.g., randomized controlled trials of health care, 
educational interventions, or other programs to address societal issues)
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• nonexperimental (observational) studies of many types, including 
surveys, longitudinal studies of various sorts (e.g., cohort studies with 
comparison groups), modeling studies, genome studies, studies based on 
patient or disease registry data, and the like. 
Within these large groupings are a vast array of study designs that need 
to be taken into account. In short, reproducibility can apply to an extremely 
diverse universe of research and to situations that run from quite simple to 
quite complex. Moreover, reproducibility may be ascribed to any one of many 
integral components that constitute an experiment, trial, or other study. 
Reliability and Validity: Related Constructs
Reliability. This concept is typically taken to mean the extent or attribute to 
which an experiment, measuring procedure, test, system or study yields the 
same results on repeated trials.76,83 Numerous aspects of reliability can be 
invoked, depending on the procedure, instrument, or test. For example, test/
retest reliability is the degree to which responses or answers on a “test” are 
consistent over time when investigators expect them to remain stable; this is 
typically assessed with correlation coefficients between results of those tests 
administered at two points that are relatively close in time, such as 1 week.
Validity. Broadly, validity takes several forms (which are catalogued differently 
in different fields). As laid out in Table 2, these elements include content 
(or face) validity, construct validity (e.g., convergent and discriminant 
validity), and criterion (e.g., concurrent or predictive) validity. Added to these 
constructs are internal and external validity—respectively, the risk of bias 
in a study and the generalizability or applicability of the data from a study 
to other populations, settings, and the like. In some research fields, one or 
more of these types of validity can be assessed or tested—for example, against 
findings from an earlier use of a test or instrument or with respect to whether 
“later” results demonstrate the ability of a predictive model to have predicted 
accurately the outcome of a given assessment or study. 
Linked relationships. Reliability and validity are often considered together 
in considering the soundness of research and research findings. In basic 
measurement terms, reliability effectively puts a ceiling on validity: studies or 
measurement techniques that are not reliable cannot be valid. 
When taken together, reasonable levels of accuracy and reproducibility (or 
reliability)—of, say, a device or measurement tool, of algorithms and models, 
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and even of a laboratory, clinical, or social experiment or a nonexperimental 
study—imply a degree of validity. The relationships can be complex and not 
straightforward, however. For example, a method or collection of methods 
used in a study can be accurate but not reproducible, reproducible but 
not accurate, neither, or both. A method is valid if it is both accurate and 
reproducible. Likewise, a study is valid if it is both accurate and reproducible.
Additional Reproducibility Concepts
Over the years, scientists have set forth different terms and usages of these 
concepts. Some are simply alternative terms or phrases, and some are more 
complex taxonomies for classifying specific types or classes of reproducibility. 
Table 2 (Chapter 2) presented taxonomies from various experts in the field.
In addition, Goodman et al. recently augmented the word “reproducibility” 
with three additional descriptors.77 Methods reproducibility is considered 
to be capturing the experimental and computational procedures, with the 
same data and tools, to obtain the same results. Results reproducibility is 
defined as producing corroborating results in a study by having followed the 
same experimental methods; this is essentially the equivalent of replication. 
Operationally, however, this goal can be elusive because of problems when 
studies have substantial random error in any result, which renders difficult 
concluding that results are “the same.” Finally, inferential reproducibility 
reflects the idea of drawing qualitatively similar conclusions from, for example, 
independent replication of a study or reanalysis of the original study. (It is not 
the same as reproducing results per se.) Such outcomes may not be possible 
if different investigators choose different analytic techniques that, even with 
the same underlying data, produce results potentially consistent with different 
inferences; in addition, researchers may well draw different conclusions from 
even the “same” results. 
Transparency 
Other distinctions about reproducibility are relevant to goals of transparency, 
documentation, and ultimately the rigor and quality of the research in 
question. Specifically, these involve empiricism, statistics, computation, 
and analytics.82,109 We briefly explored some of these concepts in Table 2 
(Chapter 2); we elaborate on them here. 
Empirical reproducibility refers to the situation in which investigators 
provide detailed information about the design and conduct of a given study.82 
This classification includes all types of experiments and trials and all types of 
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observational (nonexperimental) studies. In practice, transparency through 
making freely available both the details of how the research team collected 
data and the data themselves is what enables reproducibility in research.82 
Such documentation thus includes details of procedures, instruments, and 
methods (e.g., descriptions of study design, survey design, laboratory or field 
experiments, test subjects and materials, and all related facts about the study). 
Statistical reproducibility refers to the circumstances in which researchers or 
authors provide detailed information, independent of expectations about the 
idea of “empirical reproducibility,” that explains and documents their choices 
of statistical tests, model parameters, threshold values or cut points, and 
similar components of quantitative analysis.82
Computational reproducibility encompasses detailed information that may 
go beyond the specific research components noted above. This may include 
descriptions of hardware, software, programming code, and other details 
of the implementation or analysis activities.82 Documentation of standard 
quantitative software (for statistical testing, meta-analysis, modeling, and the 
like), such as the specific version of a statistical package (and the developer and 
city and state or country where it is located) are typical pieces of information 
expected to be recorded. An increasingly pressing and equally important issue 
is the documentation of researcher-created code. 
Analytical reproducibility enables analysts to reproduce the logical, 
modeling, and computational processes by which the original investigators had 
drawn their conclusions from a given dataset. It also implies and may require 
investigators to calculate uncertainties associated with those conclusions. The 
process may include any of the following steps: 
1. Imputing values for missing data.
2. Editing to correct data values deemed to be erroneous (including 
eliminating entire records).
3. Altering data to protect confidentiality of data subjects, which may result 
in some statistical limitations. 
4. Constructing additional variables (sometimes called composite or 
derived variables) from other variables, which can include recoding 
variables.
5. Linking the dataset to additional data.
6. Modeling the data statistically, including variable transformations, 
interactions, and choice of “tuning parameters” for models. (Examples 
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may include prior distributions for Bayesian methods; numbers and 
types of nodes for neural network models; termination thresholds for 
partition models; time windows within which an outcome must occur 
for it to be considered for adverse outcomes from pharmaceuticals; and 
selection of controls.)
7. Citing the software employed, e.g., packages such as R, SAS, or SUDAAN 
or customized software; this may include providing convergence criteria 
for iterative algorithms. 
8. Specifying thresholds (e.g., p < 0.05) and confidence intervals used to 
assess statistical significance and levels of confidence.
Investigators should also document “analyses not reported” for at least 
two reasons. First, researchers should address problems associated with 
multiple testing of hypotheses and model selection. Second, they need to avoid 
criticisms of reporting bias; these include publication bias generally but also 
selective outcome reporting bias, which can include cherry-picking results that 
favor one element of the research or another. Experts developing systematic 
reviews by seeking information from multiple sources of data (some published, 
some otherwise public, and some private) know that such reporting bias and 
selective reporting are relatively common. 
In practice, consensus is lacking about the level of detail needed to describe 
a study. Moreover, publications may not permit or provide the requisite level 
of detail. Nevertheless, describing the measurement process, the degree of 
processing of the raw data, and the completeness of the analytic reporting are 
all important parts of methodological reproducibility.77
Regulated and Nonregulated Research: Yet Another Complexity
Federal regulatory requirements have standardized, and long-standing, 
definitions for research terms such as reproducibility, repeatability, replication, 
and accuracy (see Appendix A). These are consistent with NIST definitions as 
articulated in Table 1. Nonregulatory research, by contrast, has no comparable 
driving force. Consequently, such research endeavors have more variability in 
the definitions or meaning of terms and concepts across a large array of fields 
of study. 
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Different types of scientific research are inherently easier or harder to 
reproduce. As FitzJohn and colleagues explain, for example:
At one extreme is analytical mathematical research, which should in many cases 
allow for straightforward reproduction [based on published equations]. At the 
other extreme are field-based studies, which may depend on factors that are not 
under the control of the scientist [e.g., reproducing a before-and-after study of 
the effects of a hurricane]. The current frontier of reproducibility is somewhere 
between these two extremes.110(p1) 
Guidance for Researchers: A Focus on Quality
Experts in the expanding field of reproducible research may focus more on 
definitional and conceptual classification schemes than on practical advice 
about how to proceed. The one exception is federally regulated research, for 
which considerable guidance is available (as noted above), some of which is 
related to quality (especially QA and QC procedures).
To provide some ideas about how to proceed, we present a general 
framework for a research experiment or study that involves at least one step 
of ensuring that the scientific team or others can take reproducibility into 
account. This framework focuses largely on principles of “quality” as practical 
processes. It is intended to depict at what point in the process of designing and 
conducting scientific investigations these various concepts and terms might be 
applied. 
Much of the focus is on what investigators should track, monitor, and 
report on in publications, final project reports, supplemental materials posted 
to websites, or other easily accessible venues. The underlying motivations are 
to foster transparency and strengthen the rigor of the work itself. Thus, this 
section should be seen as pertinent to both the initial studies and any later 
(related) ones. 
Study Designs and Their Relationship to Reproducibility and Related 
Principles 
Scientists have many different study designs that they can elect to adopt, and 
each study design has requirements for reproducibility. Some approaches that 
are common across many designs are critically important for the study to be 
reproducible. 
Figure 2 offers a general framework for study designs—broadly 
considered to range from experiments and randomized controlled trials to 
nonexperimental or observational studies. It highlights several conventional 
design components to illustrate which principles of reproducibility and the 
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related constructs (e.g., replicability, but also transparency and rigor) apply. 
Reproducible research in the context of this framework can refer to a single 
step, a combination of steps, or the entire process. 
The core steps discussed below pertain to both federally regulated and 
nonregulated research. We discuss some basic properties of these steps 
below. In some cases, we also note subsidiary activities related to high-quality 
research (including documentation [see Appendix A] supporting transparency 
[see Appendix B]). Supporting activities are generally listed as associated with 
the immediately preceding step so that they have been accomplished before 
they are needed. In addition, the descriptions of the steps reflect expectations 
about what investigators have done in documentation and published reports 
of the research. The remaining element—numbered 0 and discussed first—
underscores that efforts to ensure quality affect studies at every step.
Key Steps in Scientific Research
0. Ensuring Quality. Investigators (or other responsible parties) should review 
each component of the process to ensure that they are producing the highest 
quality research. This may entail, at a minimum, examining results and the 
programs in each preceding component to understand the inputs to the next 
component (see figure). Our view is that researchers should have an overall QA 
Figure 2. Key steps in experimental or observational research
Study Design 
Planning
Generate Data
Raw Data Set
Clean Data Ensure Quality
Analytic Data Set
Analyze Data
Report and 
Disseminate Results
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plan for the study and a specific QC operational plan at every step in the study: 
planning the study, cleaning raw data, creating analytic data sets, using analytic 
techniques, generating the data, creating the raw data set, and interpreting 
data and presenting results. Integrating QC into each task helps to ensure a 
comprehensive approach to quality. Conducting quality reviews for only some 
of the components, at the end of the process, or haphazardly will not produce 
the confidence in the process or product as much as a comprehensive approach 
to quality can. QA and QC are discussed further in Appendix A.
1. Planning and Designing Studies. Investigators should clearly state the 
hypotheses of an experiment or the objectives of a nonexperimental 
(observational) study. They should be specific about any assumptions they 
make that lead to or determine how the data are to be generated, analyzed, and 
reported. Two subsidiary elements are particularly important.
Training and validation. If some measures are new to a site or if staff 
members are inexperienced in administering the instrument, questionnaire, or 
laboratory technique, then training, reliability testing, validation, and similar 
tasks may need to be done. These activities help establish the validity of the 
measurement and the ability of the researcher to collect the measures precisely 
and accurately.
Curate proven methods. Investigators should explain, describe, register, or 
cite established protocols, proven code, or high-quality data (or take some 
or all of these steps), following the general expectations of their respective 
scientific fields. Curating methods and data supports efforts to make such 
information and data available to other investigators and thus to make later 
related (e.g., replication or reproducibility) studies easier to conduct and more 
accurate.
2. Generating Data. Investigators should clearly report how their data are to 
be (or were) created. This can involve conducting an assay, making laboratory 
measurements in a clinical trial, administering a questionnaire (instrument, 
survey), eliciting observations from third parties (such as family members 
or teachers), and performing numerous other data collection techniques. 
Researchers should document comprehensively all methods and procedures 
associated with data collection; they may provide such descriptions 
with detailed protocols, manuals of operations, and methods sections of 
publications (which may include web-based supplemental information in, for 
instance, peer-reviewed journals).
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3. Creating Raw Data Set(s). Data sets come directly from the data generation 
process. Invariably, some issues arise with such data sets. Examples include 
missing data (randomly or systematically), contamination of solutions used in 
experiments, or malfunctions of instruments. Knowledge of these problems 
will be informative during the data analysis phase, and investigators should 
document their concerns and the solutions. 
4. Cleaning Data. Investigators should develop algorithms to account for the 
issues they encounter in their raw data sets. Problems can be, for instance, 
inconsistent, missing, or out-of-range data values. The aim is to prepare the 
data so that the analytic data sets produced in step 5 have as few challenges or 
limitations as possible. 
Knowledge of the algorithms that investigators developed to deal with 
problems in the raw data is essential for accurate data analysis. As with the 
problems themselves, investigators should document the approaches they use 
to minimize the impact of the problems. Such actions can include making the 
data logically consistent, imputing missing values, addressing out-of-range or 
impossible values, and constructing new variables.
5. Creating Analytic Data Set(s). In principle, in steps 3 and 4 investigators 
will have resolved most, if not all, of the data issues in the raw data sets. The 
analytic data sets created from the earlier steps process are considered the final 
data sets for analysis. The investigators’ aim is to convey clearly to others what 
data they intended to analyze and how they obtained the relevant data set(s). 
6. Analyzing Data. Investigators should document equations that reflect 
the conceptual models of the trials or studies, the computer software code 
used (either uniquely written or off-the-shelf programs), and other tools 
used to calculate or estimate quantitative or qualitative information. This 
includes software used in quantitative analyses (e.g., for meta-analysis) 
and in qualitative analysis (e.g., NVivo, text analysis) that investigators will 
eventually report in various publications. As with earlier steps, investigators 
should identify, describe, or otherwise make note of these tools. All analyses 
conducted need to be documented, even if the results are uninteresting or 
statistically nonsignificant.
7. Reporting and Disseminating Results. Results comprise both the analytic 
data and the investigators’ interpretations of the information their analyses 
produced. Of particular importance, investigators must avoid all forms of 
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publication bias (e.g., actual publication bias by not publishing results at all, 
outcome reporting bias, or other selection biases). 
A Broad View of Attention to Quality in Scientific Investigations
For high-quality research to be implemented effectively, scientists should 
implement a comprehensive approach to reproducible research during the 
study design step. A narrow focus on reproducible research may frequently 
lead investigators (or those responsible for QA and QC) to focus on steps 5 and 
6 above—namely, issues about creating analytic data sets and applying analytic 
techniques and programs. Paying attention to reproducibility and related 
principles regarding all the components, and specifically steps 3 and 4, may 
also be valuable. Even if investigators (or QA/QC experts) cannot move all the 
way back to the data generation step (i.e., step 2), they can still gain valuable 
knowledge about data by examining the data cleaning step (i.e., step 4). Finally, 
step 7, where the subject matter, statistical knowledge, and understanding 
of the scientific, clinical, or policy issues come most into play, is critical in 
creating truly high-quality research. 
Even if investigators manage to execute earlier steps “perfectly,” the 
research can still fail if steps 6 and 7 are not executed as effectively as those 
earlier stages. In addition to these considerations, transparency (i.e., adequate 
documentation) in steps 1 and 2 is critical if the research is to be believed and 
used for clinical or policy decision-making or for independent reproduction or 
replication. 
One of the keys to transparent research is putting the data and computer 
programs in a state that can be shared fully, as appropriate. This may be peer-
reviewed publications, open online sharing, or private sharing if needed based 
on the provisions of contracts or grants from funders in either the public or 
private sectors. Furthermore, research teams may well hope that others will 
use their data, methods, statistical and analytic approaches, and even results in 
their own research. 
Monitoring the use of transparent products is critical not only to show the 
utility of the work, but also to provide a way to identify issues that the broader 
scientific, clinical, or policy fields may need to know. When such issues are 
identified, information about the problems that either the original investigators 
or later researchers (or both) experienced will allow future investigators to 
examine methods and protocols to determine where gaps or various mistakes 
may have occurred. In that way, they can improve their own procedures and 
move the scientific enterprise ahead.
Transparency  
in Reproducible Research
CHAPTER  4
Transparency is, at heart, based on the goal of full and accurate documentation 
of research efforts. The fundamental objective is to enable verification and 
validation of all steps leading to research results that investigators report in 
various types of publications or final reports. Achieving this entails meeting 
certain reporting standards. These may be promulgated by professional 
societies, journals and journal publishers, and federal agencies when they act 
as the publisher. 
Categories of Research Relating to Transparency
One taxonomy of several categories of research may clarify some issues at the 
publication stage, drawing on work by Stodden and colleagues.82 These include 
(1) reviewable research, (2) replicable research, (3) confirmable research, 
(4) auditable research, and (5) open or reproducible research. Appendix B 
explores these points in more detail.
We note below some basic elements for reporting research (for instance, in 
peer-reviewed journals). We also emphasize the need for making all reports of 
research conform to readability guidance for correct English, clear writing, and 
attention to the particular needs of intended audiences.111 Following that, we 
give two examples (computational sciences and epidemiology, i.e., a specific 
research field) of how specific disciplines are turning their attention to these 
issues. 
Fields of Science and Related Reporting Principles
Basic Elements of Reporting Research
The aspects of publishing on research called out below illustrate basic guidance 
for the types of information typically expected for documentation. In some 
cases, the specific expectations may be idiosyncratic to a particular field or 
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type of research; in other cases, the points are applicable across a wide array of 
investigations. The list below expands on a core set of standards for rigorous 
reporting studies set forth by stakeholders that the US National Institute of 
Neurological Disorders and Stroke convened in June 2012.112 The elements 
and the guidance cited should not, however, be regarded as a comprehensive 
list in a field evolving as fast as this one is.
Standards. Authors should follow widely accepted standards for reporting 
that are pertinent to their particular fields and types of research.112 These 
may involve (but are hardly limited to) nomenclature standards; ways to 
indicate statistical significance (e.g., as confidence intervals rather than 
simply p-values); rules for using medical terms, abbreviations, and standard 
or international units; and acceptable acronyms or abbreviations that are 
idiosyncratic to the natural, physical, or social sciences. 
A substantial array of reporting standards has also appeared in the past 
two decades. One is ARRIVE (Animal Research: Reporting of In Vivo 
Experiments) for animal studies.113 For publications reporting on trials of 
clinical interventions or health care delivery innovations, systematic reviews, 
or other types of analyses, similar guidance is available—CONSORT,114 
MOOSE,115 or PRISMA116,117 (respectively, Consolidated Standards of 
Reporting Trials; Meta-Analyses and Systematic Reviews of Observational 
Studies; Preferred Reporting Items for Systematic Reviews and Meta-
Analyses). A useful website for numerous reporting standards is the Equator 
network (www.equator-network.org/) for the main types of research studies 
seen globally. Finally, some measurement standards assess the reproducibility 
and accuracy of instruments employed in an experiment or study.
Replications. When a study is a “repeat” by the same research team using 
absolutely identical methodology, documentation requires that investigators 
report how often they performed each experiment and whether the results 
were substantiated by repetition under a range of conditions.112 Authors must 
give sufficient information about sample collection to distinguish between 
independent biological data points and technical replicates.
Sample-size estimation. Authors should be clear as to whether they computed 
an appropriate sample size when designing their study, including specifying 
the statistical method of computation.112 If they did not use a power analysis, 
then the investigators need to state how they determined their sample size. 
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Increasingly, the expectation is that investigators reporting on comparative 
studies will be clear as to whether their power calculations were based on the 
intent to show superiority vs. inferiority or equivalence.86,118 In addition, the 
notion of “optimal information size” is gaining traction.119 
Inclusion and exclusion criteria. Authors should state clearly the criteria that 
they used for inclusion and exclusion of any data or subjects and over- or 
under-coverage of the population with respect to the group from which the 
subjects were selected. These criteria may be technical metrics (using whatever 
terms might be appropriate for physical and natural science research). 
In studies involving human subjects, the criteria may reflect the PICOTS 
framework mentioned in Chapter 3 and thus might include health conditions, 
sociodemographic characteristics, and other considerations such as literacy, 
language, geographic locations, settings, and similar factors. 
Randomization. Authors should state whether their samples and study 
populations were randomized to different arms of an experiment (e.g., one 
or more intervention groups, one or more groups involving combinations of 
interventions, and control groups).112 They must also specify the method of 
randomization. For nonexperimental studies not requiring (or permitting) 
randomization, similar descriptions of controls or comparison groups in 
nonexperimental studies would also be required.
Blinding. Authors need to be clear about whether the investigators were 
blind to group assignment and outcome assessment.112 Similarly, they 
need to state whether patients or participants in studies were masked to 
their group assignment. If those assessing outcomes are different from the 
investigators (e.g., clinicians delivering care), whether they also were masked 
to the assignments of participants to intervention or control groups (or the 
equivalent in bench experiments) should be documented as well. 
Outcomes. As with study subjects or populations, authors should provide a 
complete list and definition of outcomes of interest for the study. Authors have 
an obligation to report on the results of all analyses of outcomes specified 
as part of their methods. They need to avoid all forms of publication and 
reporting bias. When not all planned outcomes could eventually be measured, 
then the investigators should explain the reasons in final publications.
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Statistics. Statistics must be fully reported in any publication. This includes at 
least three categories of information: (1) the statistical tests used (including 
specifying the tests used for different analyses when multiple tests or analytic 
techniques are applied); (2) the exact value of N (for preclinical and clinical 
studies) or values of n (for arms in a trial or groups in observational studies); 
and (3) the definitions of center, dispersion, and precision measures (e.g., 
mean, median, standard deviations, standard errors of the mean, and 
confidence intervals). 
Analytic techniques and related software. Investigators have a related obligation 
to report on all the quantitative, qualitative, or mixed methods approaches 
that they used for analysis. This is related to statistics (statistical tests), of 
course, but here the expectations extend to, for instance, direct and indirect 
meta-analyses, text and content analysis, and the increasing use of approaches 
to deal with large-scale studies of so-called complex interventions. Related 
to these items of information is documentation of the software (e.g., name, 
version, developer city, state or country) that researchers may have used in 
these analytic steps. This expectation may extend, as well, to libraries, use 
licenses, and version control.
Results. Authors have an obligation to present all results or to explain 
what is not being reported or is being reported someplace else. Thus, they 
need to clarify anything that has been omitted from the reporting for any 
reason—avoiding publication and outcome reporting biases is critical for 
audiences to have confidence in the research and the ensuing reporting of that 
research.120-123 This is especially important in specific cases: (1) when the 
results do not support the main hypotheses of the study, (2) when some results 
are discordant with the main findings, or (3) when some results are statistically 
significant and others are not at different measurement points. 
Computations
With the increasing use of technology to gather, analyze, and report data, 
reproducible research is becoming more visible in discussions of research 
methodology. An emerging area of concern, somewhat separate from the basic 
points in the previous section, is computational science and the credibility of 
calculations and results reported in various venues. For instance, verifying 
most of the computational results presented at conferences and in papers today 
is nearly impossible.50 Thus, as Donoho states, “computational reproducibility 
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is not an afterthought—it is something that must be designed into a project 
from the beginning.”14(p386)
In this context, analytical reproducibility (defined above) is the ability to 
recompute data analytic results given an observed dataset and knowledge of 
the analytic approach and steps.74 Replicability of a study is the likelihood 
that an independent experiment targeting the same scientific question (and 
with no changes to the study parameters) will produce a consistent result. 
From a computational perspective, according to Leek and Peng,74 three 
major components are necessary to achieve reproducibility and replicability. 
However, we believe that there are actually four components: 
1. Making the raw data from the experiment available. 
2. Making available the code that transforms the raw data into the analytic 
data set.
3. Making the statistical code and documentation to reproduce the analysis 
obtainable.
4. Analyzing the data correctly.
Reproducibility is a minimum expectation that can be directed at any 
study, insofar as independent investigators have the funds and time to subject 
the original data to their own analyses and interpretations.23 Reproducibility 
calls for data sets and software to be made available for all of the following: 
verifying published findings, conducting alternative analyses of the same 
data, eliminating uninformed criticisms that do not stand up to existing data, 
and expediting the interchange of ideas among investigators. Of paramount 
importance, however, is protecting the confidentiality and privacy of such data 
and not breaching any personally identifiable information requirements. 
Research-Field-Specific Transparency 
Some fields are now tackling reproducibility and transparency in ways 
specific to their disciplines and the users of their research. For instance, 
epidemiologists have asserted that a study may become reproducible when it 
satisfies the transparency criteria (i.e., requirements) noted in Table 4 for four 
core components of research.23(p784)
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Given the increasing attention now being paid to accomplishing 
reproducible research, we expect that additional fields of study, in concert with 
scientific publishing firms, will develop similar transparency requirements for 
publishing their research findings. 
Table 4. Criteria for reproducible epidemiologic research
Research 
Component Requirement
Data Analytical data set is available. 
Methods Computer code underlying figures, tables, and other principal results reported is 
made available in a human-readable form. In addition, the software environment 
necessary to execute that code is available [to other investigator teams]. 
Documentation Adequate documentation of the computer code, software environment, and 
analytical data set is available to enable others to repeat the analyses and to 
conduct other similar analyses.
Distribution Standard methods of distribution are used for others to access the software, 
data, and documentation. 
Source: Peng et al., 200623
Conclusions
CHAPTER 5
In this monograph, we have attempted to clarify the broad area of reproducible 
research, with its attendant (and confusing or even conflicting) lexicon. 
Our goal is to bring the concerns and issues into greater focus and to make 
available background information, definitions, and some practical guidance for 
all readers. 
Generally, our conclusions fall into the following categories (implicitly or 
explicitly). First, researchers must become better educated about these issues 
in general. Second, they need to grasp the similarities, and particularly the 
differences, among the concepts and terms, so that they can communicate 
clearly both within their own fields and, more importantly, across multiple 
disciplines. Third, scientists also need to embrace these concepts as part of 
their responsibilities as good stewards of research funding and as providers 
of credible information for policy decision-making across many areas of 
public concern. Restoring society’s confidence in the scientific enterprise is a 
crucial part of the responsibility of scientists and researchers across the many 
challenges facing the global community today. Fourth, a focus on transparency 
is essential, which means improving our approaches and mechanisms for 
documenting our work. Fifth, all these considerations are central to ensuring 
the soundness of the research being pursued and publicized—i.e., attempting 
to achieve the most rigorous science possible given limitations on time, 
funding, or other resources. 
Finally, we note that this is not a static field, even if experts are converging 
on standardized definitions and conceptual frameworks. More is needed—as 
practical guidance—for achieving reproducible research (broadly conceived) 
and strengthening the transparency and rigor of work across all branches of 
the natural, laboratory, and social sciences. Responsibility for accomplishing 
these goals begins with training the next generation of researchers in adopting 
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a universal lexicon of terms and concepts, applying rigorous study designs, 
and ensuring transparency in disseminating research findings—as well as 
encouraging the current scientific community to be more cognizant of issues of 
reproducibility in this era of rapidly expanding multidisciplinary collaboration 
and data. Such responsibilities belong to academic institutions, professional 
societies and associations, and research enterprises, and the obligations extend 
to funding organizations to support these efforts.
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Appendix A
Reproducible Research: Federally Regulated  
and Nonregulated Research
A significant proportion of research performed in the United States is 
not subject to federal guidelines or regulations. Notably, the reproducible 
research crisis is found predominantly in the nonregulated domain. Research 
conforming to federal regulatory requirements has standardized, long-
standing definitions for terms such as reproducibility, repeatability, replication, 
and accuracy that aid in accomplishing reproducible research. Nonregulatory 
research, by contrast, has no comparable driving force to define a lexicon. 
As discussed in this monograph, considerable discussion and confusion 
are occurring across numerous scientific disciplines about defining and 
achieving reproducible research in the nonregulated domain. Given this state 
of affairs, in this appendix we discuss federally regulated concepts and systems 
for quality research because they may be useful for consistently realizing 
reproducible research in the nonregulated arena.
Generally speaking, “regulated research” resides more in the physical and 
natural sciences than in the others. Thus, the points below pertain more to the 
natural and physical sciences (i.e., bench science) than to the social sciences 
(broadly defined). Many rules and guidelines pertain to the social sciences 
(here including clinical and social experiments as well as observational studies 
of all types)—especially when the studies involve human subjects. We discuss 
them briefly in this appendix (as “nonregulated research”). Nevertheless, 
in some cases, researchers in areas outside the bench sciences may well be 
conducting research projects for regulatory agencies and thus follow, to one 
degree or another, the precepts noted here.
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Federally Regulated Research
Promulgated Definitions, Standards, and Systems
Federal guidelines apply when researchers are producing research results 
that are to be used for federal regulatory purposes. The US Food and Drug 
Administration (FDA) and the US Environmental Protection Agency (EPA) 
adhere to Good Laboratory Practice guidelines (GLPs) promulgated by the 
federal government. The FDA also adheres to Good Manufacturing Practices 
(GMPs). The EPA adheres to GLPs per the Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA) and the Toxic Substances Control Act (TSCA). It also 
follows EPA Quality System documents such as EPA Requirements for Quality 
Management Plans (QA/R-2) (publication number EPA/240/B-01/002) and 
EPA Requirements for Quality Assurance Project Plans (QA/R-5) (publication 
number EPA/240/B-01/003). 
Research involving international applied research and analysis may also 
need to comply with various quality guidelines. These may come from, for 
example, the Organisation for Economic Co-operation and Development 
(OECD).
In addition, the following US agencies or associations have issued 
definitions and standards for research quality:
• the National Institute of Science and Technology (NIST) 
• the American National Standards Institute (ANSI)
• the EPA, particularly quality management plans and quality assurance 
project plans
• the Society of Quality Assurance.
More generally, federal regulations—particularly the Federal Acquisition 
Regulations, which provides uniform policies and procedures for acquisitions 
by executive agencies of the federal government (48 CFR Part 46—Quality 
Assurance)—codify a wide array of standards. 
Quality Assurance and Quality Control 
Both quality assurance (QA) and quality control (QC) are cornerstone systems 
of federally regulated research and should be cornerstones of nonregulated 
research, but there is no standard. QA, generally speaking, is a systematic 
activity undertaken to ensure that research and services meet client-specific 
requirements. QC involves the operational aspects of a quality system that are 
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aimed at monitoring work processes and detecting and eliminating the causes 
of unsatisfactory performance as the research is being performed. 
Many quality systems also use assessments, audits, and reviews of lessons 
learned. In keeping with the philosophy implied by the types of standards 
that agencies promulgate, we take the position (as in Chapter 4) that quality 
(QA/QC) should be built into the research conducted from the outset.
International groups issue similar guidance. They include the International 
Organization for Standardization, the Research Quality Association (RQA, 
formerly BARQA, the British Association of Research Quality Assurance), and 
the World Health Organization (WHO). 
Other groups (domestic and international) have promulgated standards for 
GLPs and GMPs, as well as good clinical practices (GCPs). The Lean Six Sigma 
Institute has similar programs in both the United States and abroad.
Office of Quality Assurance 
Federally regulated research requires that an independent Office of Quality 
Assurance provide oversight for implementation of controlled documents, 
such as standard operating procedures (SOPs), work practice documents, 
quality management plans, and quality assurance project plans. This office 
performs audits to ensure that research staff are following the instructions as 
prescribed for SOPs and use of notebooks and work practice document.
Enabling Reproducible Research Through Transparency
Given the varying definitions and the myriad issues raised throughout this 
monograph, describing how best to conduct either reproducible or at least 
transparent research is challenging. The core steps appear to lie in full and 
accurate documentation of the original work or, for that matter, “reproduced” 
or “replicated” studies. The central ideas regarding reproducibility, replicability, 
repeatability, accuracy, and validity apply across research (again broadly 
defined) in the social, natural, and physical sciences; for that reason, we have 
tried to make the ideas seamless across most fields and disciplines.
A tenet of regulated research is to document all steps employed in a study 
to provide complete transparency of how the work was performed and so 
that others can scrutinize and evaluate its validity and quality. Specifically, the 
concepts of reproducibility, replicability, repeatability, accuracy, and validity, 
as well as others, are to be proactively and qualitatively and/or quantitatively 
addressed during an experiment or study. Regulations explicitly standardize 
the definitions of these terms. 
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The fundamentals of regulatory research strive to achieve and display these 
constructs through the use of (1) SOPs, (2) notebooks to record what is done 
during each step in a study, (3) independent audits, and (4) measurement 
standards, where applicable. These fundamentals are noted here. 
Standard Operating Procedures
SOPs should be consistent with appropriate regulations from the relevant 
regulatory agency. SOPs are written procedures, developed before any research 
commences, that document how an activity is implemented. When made 
available to the client and the public, they provide transparency that enables 
reproducible research. SOPs are prescriptive in nature; that is, they provide 
exacting detail regarding how study components are to be done. Normally, a 
description of how to implement a component of a study in an SOP is based 
upon prior knowledge or experience.
SOPs address the elements of reproducibility, replicability, repeatability, 
accuracy, validation (e.g., the accuracy and reproducibility of an instrument), 
and verification—essentially, all operational components of a study. QA or 
QC steps are included in the SOPs to assess the performance of instruments, 
devices, or systems, especially reproducibility, repeatability, and accuracy. 
For example, in the natural and physical sciences, SOPs may be used for 
analytical methods, method development and analysis of biological samples, 
electrophoresis, system suitability, and column performance for liquid and 
gas chromatography, to name a few. Analytical laboratory techniques are 
described, including test material receipt, handling, and storage; labeling of 
reagents and solutions; formulation of drug substances; and water purification 
procedures, melting point determinations, and boiling point determinations. 
Data management SOPs include quality control of chemistry data. 
Work for the commercial pharmaceutical industry has additional regulatory 
requirements. SOPs or work practice documents are employed and audits 
are performed to ensure that researchers are following the procedures as 
prescribed. These practices provide transparency and enable reproducible 
research. 
Notebooks and Work Practice Documents
In addition to SOPs, researchers use laboratory or field (e.g., environmental 
work) notebooks or work practice documents in regulated research. 
Laboratory or field notebooks are essentially diaries; they capture in narrative 
form what and how a researcher conducts research from its inception to 
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its finality. The written narrative describes the objectives or hypothesis, 
experimental or study design, quality control, methods and equipment used 
to generate data, data analysis methods used, statistical algorithms used, and 
the interpretation of results. Each page of the notebook is signed and dated by 
a QA specialist in the organization’s Office of Quality Assurance to affirm that 
the narrative clearly states what and how the work was done.
Often, investigators use both SOPs and notebooks in combination. 
Specifically, SOPs prescribe what steps to perform and how to perform them in 
research work, and notebooks document exactly what was done. In addition, 
notebooks let staff record any slight deviation from the SOP or complications 
that occurred while implementing the SOP. Often, SOPs are amended to 
improve them based on actual experience from implementing them. Use of 
SOPs and laboratory or field notebooks enables the research to be reproduced. 
Use of notebooks is mandatory when conducting regulated research. This 
habit is engrained in students during their graduate training, and it continues 
when conducting regulated and, in some cases, nonregulated research. 
Audits
In the natural and physical sciences, quality assurance unit staff conduct 
internal audits and FDA and  EPA staff conduct external audits to ensure that 
detailed SOPs exist for all regulated studies. Furthermore, audits are done to 
determine whether investigators are following the SOPs as prescribed and 
to evaluate the performance of methods and instruments for replication, 
reproducibility, and accuracy. Audits provide independent verification that 
instruments are performing accurately against measurement standards from 
NIST, clients, or commercial repositories.
Nonregulated Research 
Nonregulated research generally does not conform to any detailed federal 
standards of the sort described above regarding how research is to be 
documented. Nevertheless, numerous agencies have expectations about 
protocols or specific rules concerning (for instance) informed consent, human 
subject protections, approval by the US Office of Management and Budget for 
questionnaires and other paperwork, or conduct of systematic reviews of the 
published literature. Scientists meet these expectations by documenting the 
details of their research in notebooks or work practice documents—in some 
cases perhaps less comprehensively for research-sponsoring organizations per 
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se than for the peer-reviewed journals in which staff may want to report their 
work.
Some organizations that support nonregulated or basic research projects 
may also require QA systems or activities. For example, the US Agency for 
Healthcare Research and Quality (AHRQ) asks its evidence-based practice 
centers specifically how they will exercise what amounts to QA efforts for 
producing systematic reviews and technical briefs. 
The concepts of QA, QC, and quality planning are practiced intermittently 
across domestic and international nonregulated research. QA elements may 
include training on quality and documentation during the start-up of projects. 
QC involves monitoring and evaluation activities and audits to ensure that 
research is well documented. Thus, these practices provide transparency as 
well, which enables reproducible research and analysis.
Protocols
As for SOPs, investigators in nonregulated research programs increasingly 
create and follow written protocols. Protocols may contain many of the 
characteristics of SOPs. They describe the approach investigators will use to 
perform the research in question. However, they are not specified under the 
umbrella of a regulatory requirement. Protocols may address elements of 
reproducibility, repeatability, replication, and accuracy. By their very nature, 
protocols also provide transparency to how work is performed and thus can 
enable research to be reproduced. Organizations and agencies that require 
protocols (and perhaps registration of those protocols in a US or international 
registry) include the US Patient-Centered Outcomes Research Institute 
(PCORI), AHRQ, and the US National Institutes of Health (NIH). 
Standard Operating Procedures 
Although formal SOPs may be used more rarely in nonregulated research, they 
still can have a role across all kinds of investigations. Professional societies 
in many disciplines may have recommendations concerning such practices 
for certain applications. For example, SOPs apply to survey work at RTI 
International (e.g., “Deterrence of Falsification by Data Collectors,” “Detection 
of Falsification by Data Collectors,” and “Remediation of Falsification by Data 
Collectors”). Authoritative national bodies may also issue reports defining 
standards for good practices (as from the Health and Medicine Division of 
the National Academies of Sciences, Engineering, and Medicine). The PCORI 
Methodology Committee has issued a methodology standards report that 
 Reproducible Research: Federally Regulated and Nonregulated Research 61
lays out expectations for the methods to be followed in conducting patient-
centered research in the health arena. The American Association for Public 
Opinion Research has similar requirements.
Notebooks
In nonregulated research, laboratory and field notebooks are more often 
used than SOPs. “Notebooks,” as a concept for the social sciences, may have 
a broader connotation—namely, documentation done in Microsoft Excel 
or Word files or in coding manuals. For literature or systematic reviews, for 
example, detailed documentation from searches in MEDLINE are typically 
required (search terms, order of application, and yields). 
Using notebooks (in this broader sense) is left to the discretion of the 
project’s principal investigator except insofar as agencies may require 
documentation (especially in contract work). As above, investigators may well 
specify protocols and then use both SOPs and notebooks in combination. 
Other Tools
Many domains of science have several options for software tools to help 
overcome the technical challenges of doing reproducible research.81 These 
tools enable researchers to capture and communicate the details of their 
workflow with much greater efficiency than simply writing a lengthy prose 
narrative. Thus, these tools can provide transparency that may permit 
achieving reproducible research. Numerous other software tools have been 
developed for documenting computational work. They may be grouped into 
five general types: literate computing, authoring, and publishing; controlling 
versions of documents; tracking provenance; automating steps; and capturing 
the computational environment.
Increased reliance on computational approaches in the life sciences has 
revealed grave concerns about how accessible and reproducible computation-
reliant results truly are. To this end, a specific example tool comes from 
Pennsylvania State University’s Center for Comparative Genomics and 
Bioinformatics and Johns Hopkins University’s Department of Biology. 
Together they developed Galaxy, a scientific workflow system to support 
accessible, reproducible, and transparent computational research in the life 
sciences. Specifically, Galaxy (https://usegalaxy.org) is an open web-based 
platform for genomic research.124 Galaxy automatically tracks and manages 
data provenance and provides support for capturing the context and intent of 
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computational methods. Galaxy Pages provide users with a medium by which 
to communicate a complete computational analysis.
Documenting Reproducible Research
Reproducible research entails creating and providing access to complete 
descriptions of the study designs, critical assumptions, methods, tools (e.g., for 
data collection), source code or specifics of statistical techniques employed, 
and the resulting data of the original work. Such documentation must be 
sufficient to enable other investigators, independently, to attempt to reproduce 
the initially reported results. This expectation may, however, be constrained by 
factors such as permissions granted by institutional review boards (IRBs), data 
use agreements (e.g., with federal agencies or commercial clients), or other 
client-related prohibitions.
To fulfill this expectation about documentation, researchers can create 
a package of requisite materials that describes the research process and the 
results. Such a package becomes a complete guide for both reproducing 
and extending the research. In some cases, much of the descriptive material 
(excluding results) may be found in research protocols registered with relevant 
public-sector agencies (e.g., https://clinicaltrials.gov) maintained by NIH. 
Private-sector entities also provide such services. For example, the Centre 
for Reviews and Dissemination at the University of York in the UK created 
PROSPERO (http://www.crd.york.ac.uk/PROSPERO), an international 
registry for systematic reviews. It captures features from review protocols 
in health and social care, welfare, public health, education, crime, justice, 
and international development that have some form of a health-related or 
patient-centered outcome. In addition, descriptive materials documenting at 
least some steps may be found as supplemental web-based information (e.g., 
appendices) to papers published in peer-reviewed journals or various other 
authoritative reports. 
Appendix B
Transparent Research
Transparency in Research: Understanding Basic Categories
The categories introduced here relate to reproducible—or more accurately, 
transparent—research and cover many typical research contexts. Adapted from 
Stodden et al.76 and Brandt et al.,38 they pertain to a wide range of research in 
the social, natural, and physical sciences. 
Reviewable research. Descriptions of the research methods can be 
independently assessed and the results judged credible (or not). This 
formulation of “reviewable” includes both traditional peer review and 
community review. This concept does not necessarily imply reproducibility. 
Replicable research. Investigators make available tools to allow other 
researchers to duplicate the results of their research, using precisely the same 
methods and procedures throughout. One example might be running the 
authors’ code to produce the plots shown in any publication. This particular 
process could be long and arduous, however; for that reason, investigators 
rarely take this approach. A back-up step is for investigators to make sure that 
they have adequately documented all their codes. 
Confirmable research. The main interpretations of the research can be 
attained independently without the use of any software or other tools that 
research teams (or authors) might produce. For example, other investigators 
can reproduce results by using the complete description of algorithms and 
methodology that the original researchers provide in any publications or 
supplementary materials. 
Auditable research. Researchers have archived sufficient records (including 
data and software) so that they can defend their research later if necessary 
or help to resolve differences when repeated by independent researchers. 
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Researchers may face special circumstances related to auditing that they can 
solve in different ways.
For example, the archive might be private. This is the case, for instance, with 
traditional laboratory notebooks, which may need to be made available upon 
request from US regulatory agencies such as the Environmental Protection 
Agency (EPA), the Food and Drug Administration (FDA), or the National 
Toxicology Program (NTP) of the National Institute of Environmental Health 
Sciences. In these circumstances, EPA, FDA, or NTP auditors may come to the 
researchers’ laboratories or institutions to audit the notebooks. Investigators 
might also place such information in a more public archive such as a 
repository or registry, as noted in Appendix A.
Open or reproducible research. Researchers make auditable research openly 
available. This category comprises well-documented and fully open code and 
data that are publicly available and that would allow others to
• fully audit the study procedures and computations
• replicate or also independently reproduce the results of the research 
• extend the results or apply the method to new problems.
Verification. This category entails checking that the computer code that the 
original investigators describe correctly solves the mathematical problem it 
claims to solve. Those verifying such code also need to examine whether the 
code is doing what it is supposed to be doing. For example, verification could 
be something as simple as checking that a variable was recoded as described in 
the text or as complex as a modeling function or procedure having the correct 
options set as described in the text.
For standardized software, e.g., SAS, Stata, or other commercial programs, 
validating the underlying algorithms that produce the numerical results may 
not be needed or appropriate. Instead, checking to ensure that the options that 
were supposed to be used were actually used would be appropriate. For custom 
software, verification requires examining whether algorithms are functioning 
correctly.
Validation. This category includes checking that the results of a computer 
simulation agree with experiments or observations of the phenomenon being 
studied. This element applies only if the model represents an observable 
event. Many investigators may, however, try to model events that have not 
yet happened or that occurred many years in the past. These situations pose 
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difficulties that those using validation measures need to acknowledge and 
attempt to address. 
Transparency in Research: Identifying Limitations 
This spectrum of research transparency allows both investigators and end users 
of research to better understand current practices for conducting a full range 
of natural, physical, and social science research. These categories outline what 
scientists can define and describe about their research. Such classes of activities 
help to identify limitations in any or all of the following eight components of 
high-quality research:
• assumptions made as part of designing a study 
• methods, procedures, and tools used to generate data
• how missing data are handled
• how data are curated (i.e., managed, annotated, reported, and kept safe 
and available for reuse)
• how restricted-use, protected, or personally identifiable information is 
used while protecting confidentiality and privacy
• analytic tools used to perform analyses
• quality control methods used in each step of the studies 
• interpretations of the results and conclusions drawn from those 
interpretations.
Identifying such limitations points to ways that researchers can make basic 
changes in their work to improve reproducibility. Such transparency helps 
to forestall reasons that investigators might use not to release replication or 
reproducibility “packages.”
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“The authors have written a nuanced and thoughtful primer on scientific reproducibility. By 
highlighting the social, political, and technical importance of reproducibility, together with a 
precise description of the related concepts of reproducibility, replicability, and repeatability, this 
primer provides a significant resource that all practicing researchers should read.”
Daniel Reed, Vice President for Research and Economic Development, 
University of Iowa and former Corporate Vice President, Microsoft 
“This is a well-written, clearly articulated, and timely primer on the developing and evolving rich 
terminology of reproducible research. The primer, put together by authors with deep experience 
and expertise in the topic area, focuses primarily on human-centric research in biomedicine, 
medicine, and the social sciences as well as reproducibility issues in analytics and computational 
science. The growing focus on reproducibility will open new vistas in research methodologies, 
meta analysis, comparative studies of research results, and reuse and adaptation of results 
from prior research. This primer provides an excellent overview of the subject area, and I 
would recommend it to anyone interested in coming up to speed on current issues in 
reproducible research.” 
Chaitan Baru, Distinguished Scientist and Associate Director for Data Initiatives, 
San Diego Supercomputing Center; current appointment as Senior Advisor for Data Science, 
Computer and Information Science and Engineering Directorate, National Science Foundation
Praise for 
Reproducibility: A Primer on Semantics and Implications for Research
“Pellizzari et al. have taken on the Herculean task of collecting, synthesizing, and relating the 
various interpretations of reproducibility used in the research community today, and turned the 
result into an accessible must-read guide. This important work provides a Rosetta Stone for 
various stakeholders to discuss and implement solutions that make real progress toward a 
research enterprise that routinely produces reproducible findings.”
Victoria Stodden, Associate Professor at the School of Information Sciences, University of Illinois 
at Urbana Champaign  and co-editor of the books Implementing Reproducible Research 
and Privacy, Big Data, and the Public Good: Frameworks for Engagement
